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ABSTRACT
Predicting Rupture, Death, and Dissection: The Natural History of Thoracic Aortic Disease
Ryan R. Davies, Michael A. Coady, John A Rizzo1, John A. Elefteriades,
Section of Cardiothoracic Surgery and fSchool of Epidemiology and Public Health
Yale University School of Medicine, New Haven, CT
Background - Thoracic aortic aneurysms and dissections are serious, potentially fatal diseases. Ability to
estimate simply the yearly rate of rupture/dissection would greatly enhance clinical decision making for
specific patients.
Methods - Data on 668 patients (414m, 254f) (median age 65.8 yrs) with thoracic aortic disease was en¬
tered into a computerized database over nine years. 3115 imaging studies were available. 304 patients
were dissection-free at presentation; their natural (unoperated) history was followed for rupture, dissection,
and death. In order to assess the impact of familial clustering of aortic or aneurysmal disease, family pedi¬
grees were obtained through telephone inquiry of 218 (142m, 76f) patients without Marfan syndrome
(MFS).
Results - 5-year survival in unoperated patients was 54% at 5 years. Aortic size was a very strong pre¬
dictor of rupture, dissection, and mortality. For aneurysms a 6.0 cm in diameter: rupture occurred at 3.6%
per year, rupture or dissection at 6.4% per year, death at 10.8%, and death, rupture or dissection at 14.1%
per year. At size a 6.0 cm, the odds ratio for rupture was increased 15-fold {p = 0.0041). Elective, pre¬
emptive surgical repair restored life-expectancy to normal. Of 218 patients contacted, 44 (18.9%) had one
or more first-order relatives with aneurysmal disease. Patients with non-MFS familial aggregation were
similar to those with sporadic disease, but had a trend toward higher growth rates and mortality (odds ratio
1.594, p = 0.5124).
Conclusions - This study indicates that (1) Thoracic aneurysm is a lethal disease. (2) familial aggregation
occurs in 19% of cases and may carry a worse prognosis (3) Aneurysm size has a profound impact on rup¬
ture, dissection and death. (4) For counseling purposes, the patient with an aneurysm exceeding 6 cm can
expect a yearly rate of rupture or dissection of at least 6.4% and a death rate of 10.8%. (5) Elective surgical
repair restores survival to near normal. This analysis strongly supports careful radiologic follow-up and
elective, pre-emptive surgical intervention for the otherwise lethal condition of large thoracic aortic aneu¬
rysm.
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Abbreviations

ABBREVIATIONS
The first appearance of an abbreviation occurs in parentheses following the full term. The fol¬
lowing table is provided for reference purposes:

AAA

abdominal aortic aneurysm

CAD

coronary artery disease

CHF

congestive heart failure

Cl

confidence interval

CMN

cystic medial necrosis

CT

computed tomography

CVA

cerebrovascular accident

EDS-IV

Ehlers-Danlos Syndrome Type IV

F-AAA

familial abdominal aortic aneurysm

IEL

internal elastic lamina

IMH

intramural hematoma

MFS

Marfan syndrome

MRI

magnetic resonance imaging

nMFS familial

non-Marfan syndrome-related familial

PAU

penetrating atherosclerotic ulcer

SMC

smooth muscle cell

TAA

thoracic aortic aneurysm

TEE

transesophageal echocardiogram

TTE

transthoracic echocardiogram
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INTRODUCTION

Anatomy and Physiology of the Thoracic Aorta
Structural Proteins of Arterial Walls
Collagen (especially types I and III) and
elastin are the most important structural proteins in
the aorta.6 7 Collagens consist of three polypeptide
chains which coil around each other to form threestranded ropes or collagen fibrisf^ (Figure 1) which
aggregate into “cable-like” collagen fibers .5
Secreted elastin molecules, on the other
hand, form extensive cross-links to generate a net¬
work of fibers and sheets. The exact mechanism for
their subsequent elasticity is not completely under¬
stood, but Figure 2 illustrates one hypothesis.

The

Figure 1. Diagrammatic representations of the molecular structure of
collagen. (A) An individual a-chain composed of triplet repeats (Gly-XY), X and Y are usually (but not necessarily) proline and hydoxyproline.
(B) A completed collagen fibril, a left-handed triple helix formed of
three u-chains (in different colors). Only the glycine molecule is small
enough to fit into the tight interior of the helix. Adapted from Alberts et
al.5

elastin core of the clastic fiber is covered in a sheath
elastic fiber

of microfibrils. The microfibrillar proteins appear to
act as scaffolding for the subsequent deposition of
elastin, and may also play a role in tissue homeosta¬
sis.510,11. They include fibrillin-1, whose encoding
gene, FBN1, has been identified as the defective
gene in Marfan syndrome (MFS).1’

Stretch

Relax

The Structure of the Aorta
The aorta is an elastic artery with three de¬
fined layers: the intima, media and adventitia.
(Figure 3) The intima consists of a single layer of
endothelial cells supported by a layer of collagenous

Figure 2. Hypothetical mechanism for the stretching of elastin molecules
The elastin molecules are shown in green joined together by the covalent
cross-links (red) to form a network. When relaxed, they form a loose
conglomeration of fibers (upper image), but when stretched, adopt a linear
structure. Adapted from Alberts et al.5
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tissue rich in clastin. This subendothelial tissue also
contains fibroblasts and cells similar to smooth muscle
cells (SMC) known as myointimal cells; these two cells
types are both thought to contribute to the elaboration of
extra-cellular components.
The media is a broad, highly elastic layer com¬
posed of SMC within a matrix of clastin, collagen, and

Figure 3. Elastic van Gieson stained section of the aorta (original
magnification X 20) demonstrating the internal elastic lamina (IEL)

ground substance. The elastic fibers are arranged as

elastin), has fenestrae that allow substances to diffuse to nourish
cells deep within the aortic wall. The media comprises a mixture of

circumferential lamallae. In the thoracic aorta there are

(A) and the outer part of the media have small blood vessels (vasa

delineating the intima from the media (M). The IEL (composed of

smooth muscle cells and reticular and elastic fibers. The adventitia
vasorum) and elastic and collagenous fibers.

approximately 45 to 56 lamallae, whereas the abdominal aorta contains only 28.13-15 This may contribute to
the higher prevalence of abdominal aortic aneurysm (AAA) compared to thoracic aortic aneurysm (TAA).16
The elastic lamellae play a central role in circulatory physiology: during systole, the diameter of
the lamellae increase, then, during diastole, the elastic fibers recoil: maintaining forward blood flow during
diastole.17 Thus the elastic fibers function as shock absorbers for the kinetic energy of the fluid shockwave
which strikes the aortic wall with each cardiac contraction.1*211 The medial SMC control vascular resis¬
tance, perform a macrophage-like function, and secrete collagen into the extracellular matrix/1 Deposition
of collagen continues throughout life, but humans are unable to synthesize elastic fibers in adulthood —little
elastin synthesis can be detected after infancy.22
The adventitial layer surrounds the media and maintains the maximal aortic diameter.23 It is com¬
posed of loose connective tissue consisting of fibroblasts, elastic fibers and collagen. Unlike the media, the
adventitial elastic fibers are not organized into lamellae. Collagen in the adventitia limits the maximal ex¬
pansion of the vessel and thereby determines its bursting strength.24 25 White et al. postulated that aneurysm
formation may depend on a loss of elastin’s ability to return the aorta to a normal diameter, whereas aneu¬
rysm growth may depend on the balance between degradation and deposition of collagen.26

Classification of Thoracic Aortic Disease
Thoracic aortic disease consists of a number of different disease processes, all of which may lead
to rupture and catastrophic hemorrhage. These processes include aneurysms, dissections, penetrating athe¬
rosclerotic ulcers (PAU) and intramural hematomas (IMH). Although classified separately, these are all
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intcr-rclated pathologies, and distinctions between them have
been made to facilitate descriptions of clinical presentation.

Aneurysms
TAA is simply a localized dilatation of the thoracic aorta
(Figure 4). The natural history and optimal therapy of TAA var¬
ies based on the location and extent of the aneurysm. Therefore,
Figure 4. Computed tomography (CT) of patient
with a large aortic aneurysm. (A concomitant

they arc classified largely on the basis of location (Table 1).

dissection is visible in the left posterior portion of
the aorta).

Ascending aortic aneurysms comprise approximately 50% of
TAA, aortic arch aneurysms 10%, and descending and thoraco¬
Table 1. Classification of thoracic aortic aneurysm*

abdominal the remaining 40%.29

Ascending aortic annulus of aortic valve to origin
of the innominate artery
Trans\’erse aortic arch- origin of innominate artery

Dissection

to left subclavian artery
Descending aortic: lowest margin of left subclavian

Aortic dissection occurs when a tear in the aortic intima

artery to aortic diaphragmatic hiatus
Thoracoabdominal (Crawford's classification)”
Type I

and inner layer of the media allows blood to course freely along

Type II

a false lumen in the outer third of the media. The result is a dis¬

proximal descending aorta to upper

abdominal aorta
proximal descending aorta to below

the origin of the renal arteries
Type III Distal half of descending aorta ex¬

section flap that traverses the aortic lumen, dividing the aorta
into true and false lumina (Figure 5 and Figure 6). The misno-

tending into the abdomen
Type IV Most of/the entire abdominal aorta
* Adapted from a table by Pitt and Bonser.”

mer dissecting aortic aneurysm has been used to describe this process. But in the acute setting, dilatation
of the aorta does not occur. Rather, if the patient survives the acute event, gradual dilatation of the false
lumen will result.1" Therefore, we prefer the term aortic dissection to indicate the splitting of the media by

Figure 5. A. The three layered aortic wall, the intima (red) lines the lumen, the ad¬

Figure 6. Computerized tomography (CT) of a patient with a

ventitia (yellow) forms the external layer, and the media (pink) sits between. B A tear

classic type B aortic dissection

through the intima allows a column of blood to split the layers of the media

presence of both true and false lumina.

This

Note the intimal flap and

leads to the intimal flap crossing the lumen, and dividing it into the true lumen (upper
left) and false lumen (lower right)

3
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circulating blood, and the term
aortic aneurysm to indicate a dila¬

tation of the aorta.
Clinically, dissections
identified within 2 weeks of the
onset of symptoms are classified as
acute', subsequently they arc termed
chronic. There are two classifica¬

tion systems which indicate the
extent of the dissection in the aorta.
The simplified DcBakey classifica¬
tion consists of three types, while
the simpler — and more commonly
used —Stanford classification rec¬
ognizes two. (Figure 7)
Figure 7. The classification of aortic dissection. The top row shows the Stanford classification, the
bottom the simplified DeBakey classification

Penetrating Ulcer

Stanford type A includes any dissection with involve¬

ment of the aorta proximal to the left subclavian artery, (this includes both DeBakey type I, which
extend the length of the aorta, and DeBakey type II, which are confined to the proximal aorta). Stan¬
ford type B and DeBakey type III are equivalent categories comprising dissections limited to the aorta

In PAU, atheromatous

distal to the left subclavian artery

Included with the Stanford classification is the incidence of intimal

tears in each region of the aorta based on autopsy studies. Adapted from a diagram by Ergin and
Griepp.30

plaques ulcerate and disrupt the
internal elastic lamina. The ulcer
then penetrates through the intima into the
aortic media.31 ’’(Figure 8). Although this
may precipitate a localized intramedial dis¬
section, in contrast to classical aortic
dissection, this localized process is limited
by areas of severe calcification associated
Figure 8. Diagram of PAU. A. An atherosclerotic plaque penetrates through the

with the locally advanced atherosclerotic

intima into the media. B With time, an intramural hematoma may form, but it will
be limited in extent by fibrotic and calcified tissue.

disease.3435 The natural history and optimal

4
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treatment of PAU is only now beginning to be ex¬
plored36 as better imaging teehniques (including
MRI. Figure 9) allow for non-operative diagnosis.

Intramural Hematoma
Whereas classical aortic dissections are
thought to begin with a tear which allows blood to
dissect rapidly along a plane in the outer third of an
intrinsically diseased media, IMH is thought to oc¬
cur following rupture of the vasa vasorum in the
aortic wall.34 This was first described in 1920 by
Krukenberg as a “dissection without intimal tear.”
A diagrammatic representation of IMH can be seen
in Figure 10, and Figure II shows the appearance
of IMH on transthoracic echocardiogram. The rela¬
tionship between IMH, PAU, and classical
dissection has not been established. They may in
fact lie on a continuum with dissection, and much

Figure 9. A MR image (sagittal view) of a patient with a penetrating
atherosclerotic ulcer. The penetrating atherosclerotic ulcer is diagnosed by

work remains to clarify their pathophysiology, natu-

Figure 10. Diagram of IMH

visualization of a distinct ulcer crater in the absence of an intimal Hap or
false lumen B MR image (axial view) of a patient with a penetrating
atherosclerotic ulcer

Blood in the media

(possibly secondary to a rupture of the vasa
vasorum leads to a concentric hematoma without
intimal tear

Figure 11. Transthoracic echocardiogram (TEE) of a patient with an
intramural hematoma

Note the absence of intimal disruption or

penetrating atherosclerotic ulcer.

5
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Introduction

ral history, and relationship to classical dissection.34

Familial Aggregation
Because this paper examines familial aggregation as a risk factor for complications in thoracic
aortic disease, and no standardized terminology exists for the various types of aggregation described in the
literature, it is important to define the use of some terms. Patients with the diagnosis of MFS, MFS-related
syndromes, or other inherited systemic diseases of the connective tissue are referred to as syndromic pa¬
tients. Those patients without such a history, but whose families do illustrate familial aggregation or
clustering' of disease are termed non-syndromic familial aggregation or non-MFS-related familial aggre¬
gation (abbreviated throughout this paper as nMFS familial), because in thoracic aortic disease MFS is the
predominant inherited syndrome involving a connective tissue defect. Those patients without any evidence
of familial aggregation are termed sporadic.

Thoracic Aortic Aneurysms
History
Arterial aneurysms have been recognized since at
least the 2nd century AD, when Galen (Figure 12) is credited with the first description. At the time, he recognized
the catastrophic implications of aneurysm rupture, noting.
“if an aneurism be wounded, the blood is spouted out with
so much violence that it can scarcely be arrested.”37 The
great anatomist Vesalius is credited with the first correct
clinical diagnosis, in 1557,37 Since then, speculation as to
the cause or causes of aneurysm have continued unabated;
unfortunately, almost 450 years later, they remain—to a
large extent—unclear.
Figure 12. Early depiction of Gaien. Courtesy Cushing/Whitney
Medical Library at Yale University, Historical Library.

’ Different studies will define familial aggregation differently, for example, they may include families with a history of sudden death,
but without confirmed aortic disease, or they may include any family member or restrict it to first-degree family members. Our defi¬
nition will be explained below in the Methods section. The definition used in other studies will be noted where appropriate.
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Much of what we do know about thoracic aortic aneurysms (TAA) has been extrapolated from
studies of abdominal aortic aneurysms (AAA); less scientific evidence is available on TAA. While the
known risk factors described in the abdominal aorta are probably important in the thorax, differences be¬
tween AAA and TAA necessitate a complete understanding of TAA independent of abdominal disease.

Etiology
Normal vessel wall biology involves a balance between the distending forces placed on the aorta
by the flow of blood under pressure and the ability of the aorta (through the structural integrity of the aortic
wall) to resist dilatation and elastically rebound when the pressure pulse of each cardiac systole has passed.
Therefore, factors which either (1) decrease the ability of the aorta to resist distention or, (2) increase the
distending forces would be expected to result in aneurysmal dilatation. In aortas weakened by processes
such as genetic defects, atherosclerosis or inflammation,38"10 normal aging,41,42 prolonged hypertension,35 or
cigarette smoking,43"17 factors increasing the load on the aorta may increase the risk of aneurysmal dilata¬
tion. These factors include hypertension,48'52 the process of dilatation itself, and the location of the
weakening along the course of the aorta. Thus, the etiology of aortic disease involves a complex interplay
between a variety of factors contributing to weakness of the arterial wall and increased aortic wall pres¬
sure.53

Natural History

Epidemiology: Incidence and Prevalence
Because aortic aneurysms are a frequently silent disease, precise estimates of incidence and
prevalence have been difficult to obtain. Changes in the incidence and prevalence due to changing disease
patterns have further complicated the matter.50,54,55 The most recent evidence suggests that the incidence of
TAA is approximately 5.9 per 100,000 patient-years.29 This is consistent with published autopsy rates of
437 per 100,000 in women and 489 per 100,000 in men.56
Traditionally the incidence has been thought to be higher in men than women;57'59 however, this
likely reflects the greater number of men seen in a referral population and possibly a higher rate of recog¬
nized syphilitic aneurysms in men, rather than a true difference in the occurrence of aneurysms in the two
sexes.

29
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Growth Rates of Thoracic Aortic Aneurysms
One might expect that the calculation of aortic growth rates is a simple process. Simply take the
last size measurement (S;), subtract the first size measurement (Sf) and then divide by the time interval (7)
between them:
Equation 1. Traditional growth rate formula

Gr =

Si-Sf
T

However, that method is highly subject to measurement error, especially when the time between
studies is short. In order to account for measurement error, some groups truncate negative growth rates to
zero; others exclude them from analysis. These divergent methods may explain some of the variation in
their results. In studies of descending and thoraco-abdominal aortic aneurysms, growth rates have varied
from 0.2 cm/yr60 to 0.32 cm/yr61. The variation among growth rates when all sites are measured together is
even higher: 0.10 cm/yr62 to 0.42 cm/yr63.
Despite the disparities in the exact rates, some consensus exists as to which factors are associated
with higher relative rates. Chronic obstructive pulmonary disease (COPD) has been associated with faster
growth rates in multiple studies.51-60 The reason for this association is not clear. Although one might pos¬
tulate that it reflects differences in smoking behavior,61 or genetic differences in susceptibility to connective
tissue disease leading to both increased risk of COPD and increased aneurysm expansion rates.60 Alterna¬
tively, thoracic physiology and mechanics, which undergo significant changes in patients with COPD, may
influence the expansion rate in these patients.
Initial aortic size greater than 5 cm has been associated with higher relative growth rates,6164 as has
the presence of renal failure64. Interestingly, as noted above, a history of hypertension has not been found
to be associated with either faster growth rates or an increased susceptibility to rupture.61’65 The only ex¬
ception to this, the study by Masuda et al.,64 measured diastolic blood pressure rather than examining a
history of hypertension. This supports the idea that adequate treatment of hypertension mitigates the po¬
tentially increased risk associated with a history of such disease; follow-up with serial blood pressure
measurements is the only way to clarify the relationship.

Finally, the presence of chronic dissection has
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been identified as a predictor of higher growth rates in our previous work;66 however, this has not been
shown universally.61
Complications: Rupture and Dissection
The main complications associated with aneurysms are rupture and dissection, either of which
may result in subsequent death. As noted above the silent nature of TAA has made epidemiological char¬
acterization of the disease difficult. In addition, the high mortality rates and the selection of patients for
surgery lead to several sources of bias in studies of predictors of complications. Few groups have at¬
tempted systematic statistical analysis of risk factors for complications in TAA to enable the optimal
selection of patients for surgical extirpation of their aneurysm.
Learning from Abdominal Aortic Aneurysms
Research into the complications of AAA has provided some insights into the behavior of aortic
aneurysms. However, given the differences between the diseases, extrapolation of those results to TAA
should be done cautiously, especially since surgery for the thoracic aorta carries significantly different risks
than surgery of the abdominal aorta.
Traditionally, size has been the best predictor of AAA rupture.67,68 Szilagyi showed that the natu¬
ral (unoperated) history of AAAs > 6 cm had 5 year survival of only 6%, compared with survival of 48% in
those with smaller aneurysms.69 Hypertension and COPD are independently predictive of higher rupture
rates.68,70 71 Because the incidence of COPD is so intertwined with the prevalence of tobacco use, it has
been difficult to separate the influence of the two factors.72 But, in studies which have examined both to¬
bacco use and COPD, COPD has consistently been the stronger predictor.68 71
The impact of higher expansion rates on rupture risk has similarly been difficult to separate from
the related increase in absolute aortic diameter. Some studies have found both to be predictive, while oth¬
ers have not.68 Dr. Cronenwett succinctly summarizes the difficulty in obtaining a full understanding of the
natural history of aortic disease: “It would require ... a large series of patients with comparably sized
AAAs but different expansion rates .followed without intervention, to determine whether expansion rate per
se, or only final AAA size is an independent predictor of rupture. Unfortunately, these results are not
available.”68
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Thoracic Aortic Aneurysms
Until recently, most of our knowledge of the natural behavior of TAA (outside of what we have
learned from analysis of AAA) was derived from a small number of observational studies, and some popu¬
lation studies. The first systematic investigation of TAA was done by Boyd in 1924 ” While this study
described the consequences of rupture, it made no effort to examine risk factors for rupture. Population
studies have revealed an incidence of ruptured TAA of approximately 5 per 100,000 population.74 Cumula¬
tive risks for patients with TAA are substantial: Bickerstaff, et al.29 reported a cumulative rupture rate of
51% for aneurysms without dissection. Mortality following rupture was a devastating 94%.

Subsequent

work by Kampmeier suggested that arch aneurysms have a worse prognosis,75 but no other attempt to de¬
lineate groups at increased risk was attempted. While many of these studies followed large populations,
they did not attempt to use detailed statistical analyses to understand predictive factors for rupture and
thereby establish criteria for surgical intervention.
More recently, Presslcr and McNamara followed a group of 260 patients and looked at the timing
of rupture.57 Late rupture (more than three days following diagnosis or onset of symptoms) accounts for
91% of TAA rupture, and 68% of TAA ruptures occurred more than one month after diagnosis.57 Rupture
accounted for 44% of deaths in their series.57 However, none of these studies addressed the important
question of which patients were at highest risk for early rupture.
Previous work in our group showed that high initial aortic size was highly predictive of rupture
and dissection.66 In the ascending
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incidence of complications at these size ranges (Figure 13). However, separate analyses were not per¬
formed to identify other risk factors for either rupture or dissection. Furthermore, this data provided a static
“snap-shot" of risk and failed to examine the risk of complications over time, so that a patient followed for
one month who ruptured had the same impact on the analysis as a patient who ruptured following a fiveyear follow-up.
The group at Mount Sinai

Equation 2. Gnepp’s formula for prediction of rupture within one year of size measurement

led by Dr. Griepp has published de¬
Probability of rupture within 1 year = 1 -e ^j65)
tailed analyses of the incidence of

where In A = -21.055 + 0.093(age) + 0.841 (pain) + 18.22{COPD)

rupture in patients with descending
or thoraco-abdominal aneurysms.65

+0.643(descending diameter, cm)
+0.405(ascending diameter, cm)

Using a logistic regression analysis they were able to provide a multivariable equation to enable the predic¬
tion of rupture within one-year based on specific patients characteristics (Equation 2) . However, thenanalysis was limited to aneurysms of the descending aorta, and their work did not analyze the incidence
over time but instead looked at incidence within a set time period.
Intuitively, one would expect that hypertension would increase the risk of rupture and dissection,
but that has not been demonstrated in any studies.65,66 This may be due to the fact that patients with identi¬
fied aneurysms tend to be treated medically with (3-blockade, thereby minimizing the effect of a history of
hypertension.65 This possibility is supported by the fact that although hypertension predicts higher initial
aortic sizes,61 it does not predict higher growth rates in most series.61,66 (A study by Masuda, et al76 is one
exception). Juvonen and associates identified chronic obstructive pulmonary disease (COPD) as the risk
factor most predictive of rupture.65 This is consistent with studies of AAA as described above.
Growth rates measurements have been highly variable (see Growth Rates on page 8). So it is not
surprising that examination of growth rates as a risk factor for rupture has been inconsistent. Some studies
have correlated higher growth rates with rupture,61 but others have not been able to demonstrate a similar
association.60
It is important to note that complications other than rupture or dissection may occur in these pa¬
tients. These less catastrophic complications include aortic regurgitation which may occur in ascending

it
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aneurysms,77 hoarseness due to compression of the recurrent laryngeal nerve by aortic arch aneurysms, and
dysphagia or dyspnea due to pressure on the esophagus or trachea.73'75
Mortality
Despite their rarity, aortic aneurysms (both AAA and TAA) are the 13th most common cause of
death in the United States, and their prevalence appears to be increasing ,78'79 Overall 5-year survival in
patients with TAA is only 56%.80 In 1964, Joyce, et al. demonstrated that patients with aneurysms less than
6.0 cm in diameter had a 5-year survival rate of 61%, while those with aneurysms larger than 6.0 cm had a
5-year survival rate of only 38%.59

Since then, little work has further delineated nsk factors predictive of

mortality in this population, and no further examination of the predictive power of aortic size on mortality
has been done (probably because of the large sample sizes and detailed follow-up required). Mortality in
these patients may be attributed to both dissection and rupture.81'83
Our previous work has shown that survival is significantly worse in patients with descending or
thoraco-abdominal aortic aneurysms (39% at 5 years) than in aneurysms of the ascending aorta or aortic
arch (77%,p ^.(Bl).66 In addition patients with a concomitant dissection have poor long-term prognosis
independent of aneurysm location (46% at 5 years).84 Symptomatic aneurysms also have poor prognosis
when compared to asymptomatic disease (5 year survival 26.9% versus 58.3%).84

Treatment
Advances in the surgical treatment of thoracic aortic disease have led to significantly improved
early and late results in recent years. However, surgical repair of the thoracic aorta still carries significant
risk. Because aortic aneurysms are often asymptomatic until rupture or dissection, identifying those pa¬
tients who are at risk for complications is central to optimal surgical therapy. Operate early on patients at
low risk and the risk of complications may not justify the risk of surgery, but operate too late and rupture or
dissection may occur, necessitating an emergent intervention with higher morbidity and mortality.
Some patients clearly require surgical intervention, including those with Type A dissections, those
who are symptomatic, and those with rapidly enlarging aortas. However, a substantial portion of patients
lack these indications for surgery but remain at risk for serious complications. Identifying those patients at
highest risk remains a significant challenge.
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Rupture occurs in 32% to 68% of patients not treated surgically, and 1-, 3- , and 5-year survival
estimates for patients not undergoing surgical repair are approximately 65%, 36%, and 20% respec¬
tively.29,57’85 In contrast, mortality from elective repair at experienced centers may be as low as 2%,
although estimates range as high as 9%.66,86 The high mortality rate (up to 21%)66 from emergent proce¬
dures reinforces the need to identify patients at risk for rupture and operate sooner and electively.
For patients not considered good operative candidates, the options for medical therapy are limited.
Currently, (3-blockade is the mainstay of medical treatment. It is thought to exert beneficial effect through
a reduction in pulse-pressure, mean pressure, and heart rate.87 Although it has been shown to reduce the
rate of aortic root dilatation and the development of aortic complications in patients with Marfan syn¬
drome,88 its use in non-MFS patients has recently come under significant scrutiny because of its effects on
vascular wall compliance.

The Inheritance of Thoracic Aortic Disease
Marfan Syndrome and Inherited Connective Tissue Disease
Systemic disorders of connective tissue proteins, such as Marfan syndrome (MFS) and EhlersDanlos syndrome type IV (EDS-TV, resulting from defective synthesis of type III collagen), are known
causes of dominantly inherited aortic disease. In the case of MFS, 99 different mutations in the fibrillin-1
gene (FBN1) have been identified in patients with MFS and Marfan-related syndromes.89 Patients with
MFS and related syndromes present with a variety of connective tissue symptoms, including skeletal mani¬
festations,90,91 ocular manifestations,90 and cardiovascular manifestations (especially aortic root enlargement
and Type A dissections).909293 To date, no genotype-phenotype correlation between the physical location
of the genetic defect and the systemic manifestations of disease has been identified.93
In MFS, mutations in FBN1 cause abnormalities in the synthesis and extracellular deposition of fi¬
brillin.

Patients with decreased amounts of deposited fibrillin-1 have more severe cardiac complications

and undergo aortic surgery at an earlier age.94 The pathogenesis of the mutant FBN1 gene to be of the
dominant negative type, where the phenotypic expression depends on the presence of the mutant fibrillin-1
rather than decreased concentration of wild-type protein.95'97 Additionally, the mutant-type protein may

13

Introduction

Davies et aL - The Natural History of Thoraac Aortic Disease

disturb aortic wall homeostasis in the adventitial layer.10 Further work must be done to define the precise
relationship between defective fibrillin synthesis and aortic dilatation.

Familial Inheritance in Patients without Systemic Connective Tissue Disease
Familial aggregation of AAA in patients without known hereditary connective tissue disorders,
was noticed as early as 1977.98 Subsequently, Tilson and colleagues described 50 families in which more
than one individual had been diagnosed with AAA.99'101 Further work demonstrated that 19% to 33% of
patients with AAA had a family member who also had clinically diagnosed disease.10‘ l0?
Familial aggregation of aneurysms and dissections in

0T0
patients with thoracic aortic disease was noted as early as
1967,105 but further case studies were not added until after the
increased interest in familial AAA (Figure 14).104 '06 Biddinger

Ot4m=]

0

O

& i i (!) 61 h i i i i

et al. went further and in a case-control study, examined the
prevalence of thoracic aortic disease (TAA, aortic dissection,
and sudden death) in probands with disease compared to the

Figure 14. Pedigree of a family demonstrating aggrega¬
tion of thoracic aortic disease identified by Nicod, et al!M
Circles represent women and squares men. Affected
members are represented by black circles or squares.
Possibly affected members are represented by grey circles
or squares. Diagonal bars indicate deceased members.

families of their healthy spouses.107 The relative risk for tho¬
racic aortic disease in the families of probands ranged from 1.8 to 10 for sisters and brothers respectively.
More recently, research groups have begun to examine these patients for molecular and genetic
defects. Two separate groups have identified patients in whom disease can be attributed to mutations in
FBN1, the same gene implicated in MFS.108 109 Thus mutations in FBN1 can cause a range of phenotypic
disease from isolated aortic disease to systemic MFS: again no genotype-phenotype correlation has been
postulated. Less clear was whether or not other genes might be responsible for non-MFS-related familial
aggregation; especially since these two reports examined a total of only three probands.

Impact of Familial Aggregation on Natural History
The natural history of aneurysms due to MFS and MFS-related disorders reveals poor long-term
prognosis in these patients. In 1972, mean age at death was 32 years, but by 1993 it was 41 years, and me¬
dian expected survival in the living population had increased from 48 to 72 years.' '0J'' However, patients
with MFS are more likely to have aortic regurgitation in association with ascending aneurysms than pa-
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Also, despite improved survival, patients with MFS continue to require

repeat aortic surgery at higher rates (25% versus 0% for non-MFS-related aneurysms).112
Because of small sample sizes, the natural history of aortic disease in patients with nMFS familial
disease as compared to sporadic cases has not been adequately assessed. Biddinger et al. have performed
the only analysis for thoracic aortic disease. They noted that there was no statistically significant difference
in the incidence of hypertension in the probands versus their spouses/controls; however, the controls were
unaffected individuals, not individuals with sporadic aortic disease.107 More substantial work has been
done examining the impact of family history on the course of disease in AAA.101113114 Darling et al., found
that patients with familial AAA and a female family member with an aneurysm had an increased risk of
rupture (63% versus 37%,p < 0.05).113 They used the term black widow syndrome to describe this in¬
creased risk. On the other hand, there was no difference between the patients with sporadic and familial
AAA in terms of anatomic extent of disease, multiplicity of aneurysms, or associated occlusive disease.
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STATEMENT OF PURPOSE
Thoracic aortic disease consists of four entities: aneurysm, dissection, PAU and IMH, all of which
have high mortality and morbidity rates. On the other hand, surgical repair of the aorta, particularly regions
with branch vessels to the brain or spinal cord is difficult, and it carries substantial risk of paraplegia, stroke
and death. Therefore, in order to provide realistic prognostic information, guide the timing of surgery, and
ultimately improve the outcome in these patients, detailed knowledge of the risk factors associated with
poor outcomes—both with and without surgery —is required.
Heretofore, anecdotal evidence has been the mainstay of literature on diseases of the thoracic
aorta. Thus, despite detailed knowledge of the histopathology associated with aneurysm and dissection, the
etiologic events leading to aneurysmal dilatation in some people and dissection in others despite pathologic
findings similar to healthy controls remain unknown.

Instead, successive authors have postulated different

theories which have been difficult to substantiate experimentally and unhelpful in establishing high-risk
groups for complications (outside of the comparative risk associated with type A versus type B dissec¬
tions).
Despite an extensive literature examining autopsy findings, describing techniques for surgical re¬
pair and reporting post-operative outcomes, little literature has focused on the question of which patients
merit surgery and when. Small sample sizes and early selection for surgery have mitigated the statistical
power of most series.

Our group has published a frequently cited report66 examining size as a risk factor

for complications, but even this paper examining 230 patients lacked the statistical power to look at com¬
plication risk over time.

Some risk factors, including the impact of a family history, were also ignored.

The group led by Dr. Griepp at Mount Sinai have published the only prospective examination of rupture,65
but it was limited to patients with descending and thoraco-abdominal aneurysm, and did not address those
patients with ascending or arch aneurysms.
Given the apparent differences between the behavior of aortic disease in patients with MFS and in
those without syndromic family history,66 non-syndromic patients with a family history may also be at
higher risk for rupture. Although family history of AAA has been extensively examined, little is known
about non-syndromic family history in TAA, and its impact on outcome has not been assessed.

16

Davies et aL — The Natural History of Thoracic Aortic Disease

Statement of Purposi

Therefore, much remains unclear about the etiology and optimal treatment of patients with tho¬
racic aortic disease. Much must be learned if we are to provide effective timing of surgical therapy in these
patients. In this paper, we examine nearly 700 patients with thoracic aortic disease seen at the Yale Center
for Thoracic Aortic Disease between October 1985 and December 2000. This analysis aims to define spe¬
cific yearly predicted rates of complications and death in this population and sub-populations composed of
patients with a variety of risk factors in order to develop simple, scientifically-based prognostic indicators
and surgical intervention criteria for patients with TAA and dissection.
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METHODS

Patients and Data Collection
The patient population we analyzed consisted of all patients seen at the Yale Center for Thoracic
Aortic Disease during the period October 1985 to December 2000. This population was initially collected
in 1996 through retrospective analysis of hospital records as described in our previous publication.66 Later,
patients were added by the author to the retrospectively-collected population through the prospective addi¬
tion of patients to a computerized database.

Initial Recruitment of Study Population
Patients were initially enrolled in the study by Dr. Michael Coady, Dr. John Rizzo and Dr. John
Elefteriades after a computerized search had been conducted by Dr. Coady of all patients undergoing mag¬
netic resonance imaging, computed tomographic scanning, or echocardiography of the thoracic aorta at
Yale-New Haven Hospital from October 1985 to March 1996. The search was formatted to exclude pa¬
tients who had normal aortic diameters (defined as patients with ascending or descending thoracic aortas of
less than 3.5 cm in diameter) and no evidence of dissection, PAU or IMH. A search was also conducted to
identify patients undergoing aortic operations, and autopsy records were examined for all patients who
died of aortic disease during this time period. This initial recruitment phase identified 230 patients with
thoracic aortic aneurysm.

Prospective Recruitment of Study Population
Subsequent to the collection of the initial population described above and the publication of some
initial reports with this smaller sample size, the decision was made to begin the prospective addition of pa¬
tients seen at the Yale Center for Thoracic Aortic Disease to the database. All patients diagnosed with
aortic disease seen at the Yale Center between April 1996 and December 2000 were included. At the time
of initial surgical consultation, datasheets were filled out by the consulting physician. Data collected at that
time included a history of symptomatic or asymptomatic aortic disease, past medical history including de¬
tailed information about specific risk factors for vascular disease, past surgical history, and previous
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imaging studies. In total, 438 patients with aneurysm (182 with concomitant dissection) and 72 patients
with dissection alone were collected prospectively.

All Patients
In total 668 patients have been identified and compiled into the database (414 with TAA in the ab¬
sence of dissection and 254 with dissection—of these, 26 patients with PAU were identified and 23 were
identified with IMH).
A hospital chart review was then conducted on identified patients (chart review on the initial
group of patients was performed primarily by the authors of the initial paper,66 although additional data on
all patients was collected subsequent to the author joining the project by a variety of researchers including
the author. Dr. Michael Coady, Dr. Lee Goldstein, and others). Specifically, the author (Mr. Davies) per¬
formed data collection on 314 patients. Data recovered from hospital records and computer files were
cross-checked by Dr. Rizzo with hospital discharge abstract data monitored by the Connecticut Hospital
Association and Connecticut State Mortality Records. Risk factors for vascular disease were assessed (to¬
bacco use, diabetes mellitus, hypertension, lipid profile, cardiac disease and renal dysfunction), as were a
variety of other risk factors for morbidity and mortality (pulmonary disease, cancer). Where possible, risk
factors were graded as mild, moderate, or severe according to the suggested standards for reports pertaining
to lower extremity ischemia as formulated by the Ad Hoc Committee on Reporting Standards of the Soci¬
ety of Vascular Surgery and the International Society of Cardiovascular Surgery of North America.115
Where severity could not be established, we conservatively graded the disease as mild.
In defining the type and extent of aneurysmal disease at presentation, presentation with aortic dis¬
ease was considered to occur at the first presentation to any medical professional with the symptoms of
thoracic aortic disease (or in the case of asymptomatic disease, the presentation at which the disease was
discovered). When a patient’s first presentation occurred outside of Yale-New Haven Hospital, data was
recovered from other health care providers where possible. Otherwise, the unavailable information was
coded as such in the database, and those patients were excluded from analyses requiring unavailable infor¬
mation.
Periodic re-review of computerized hospital records—particularly imaging studies—was also per¬
formed. This re-review (performed by the author) occurred on a bimonthly basis for a selected group of
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active charts so that each chart was examined at least once per year. A computerized database was main¬
tained initially in Microsoft Excel as part of ongoing studies at the Yale Center for Thoracic Aortic
Disease, a major referral center for New England. Subsequently, this database was converted to a relational
database designed by the author in Microsoft Access2000 (©2000, Microsoft, Inc., Redmond, WA) and
continues to be maintained by the author at the Yale Center.
The database includes 3115 radiographic studies (985 CT scans, 418 MRI scans, 139 TEE studies,
1344 TTE studies, and 229 angiographic studies) and 20 intra-operative size measurements performed on
patients with thoracic aortic disease, all compiled by the author.

Dinsmore, et al."6 have reported a high-

degree of correlation between CT, MRI and echocardiography, so measurements from these modalities
were combined (they continue to be maintained separately in the database so that with larger sample sizes,
we may be able to examine the differences between them). Size measurements during aortic angiography
are less accurate, and often result in significant magnification of the aneurysmal aortic diameter; therefore,
although angiographic data was used to identify the presence or absence and type of aortic disease in these
patients, size measurements made at angiography were excluded from analysis. The thoracic aorta was
considered aneurysmal if it attained a maximal diameter of 3.5 cm or greater.
During the 15-year period, a total of 397 patients out of the 668 underwent surgical treatment of
the thoracic aorta. There were 259 elective procedures, and 138 emergency procedures.

Operations in¬

cluded 283 procedures on the ascending aorta or aortic arch (93 emergent and 190 elective), and 114
procedures on the descending or thoracoabdominal aorta (45 emergent and 69 elective). Operations on the
ascending aorta were performed with the use of cardiopulmonary bypass with myocardial preservation by
systemic hypothermia, topical hypothermia with iced saline solution, and cold crystalloid or blood car¬
dioplegia. Deep hypothermia and circulatory arrest were used uniformly for arch replacements and
liberally for the distal anastomosis of ascending aortic replacements. Since 1987, operations on the de¬
scending aorta have been performed routinely with the use of left atrial-femoral artery bypass with a
centrifugal pump without an oxygenator, except when the patient’s condition was not stable enough for
cannulation; in this case, the operation was done by the “clamp-and-sew” technique.
Recent data from our group has identified stroke as a common complication in operations on both
the ascending and descending operation.117 The majority of strokes resulted from embolic sources; there-
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fore, since 1999, additional protective techniques have been employed, including: care in the mobilization
of the descending aorta, debridement of atherosclerotic aortic cuffs, TEE-guided location of cannulation
and perfusion sites, C02 flooding of the operative field, placement of the proximal clamp prior to the insti¬
tution of femoral perfusion in descending operations, and avoidance of cannulating a fibrillating left atrium

Growth Rates
Of the 668 patients with thoracic aortic disease, there was a core group of 332 patients who were
observed with serial imaging studies. Serial imaging consisted of 2 or more size measurements separated
in time. This group of 332 patients consisted of 190 individuals with aneurysms of the ascending aorta, 24
of the aortic arch, 40 of the descending aorta, and 78 of the thoraco-abdominal aorta. Dissection was pre¬
sent in 129 patients and absent in 203. The period of serial radiological follow-up prior to surgery ranged
ffom 0 to 171.7 months, with a median of 19.1 months. These patients were followed longitudinally and
this sample was used to estimate aneurysm growth rates and to identify risk factors affecting aneurysm
growth in a multivariable model.

Analysis of Complication Rates in Thoracic Aortic Aneurysms
Of the 668 patients in the database, 304 patients met the inclusion criteria for the analysis of com¬
plication rates.

Inclusion criteria were as follows: aortic size s 3.5 cm and age > 6 years at presentation.

absence of congenital aortic malformations (for example, aortic

Table 2. Distribution of 92 end-points.*
Events

coarctation), absence of chronic dissection at presentation, and at least
one size measurement prior to operative repair.
These 304 patients form the basis for the analysis of compli¬

# patients

dissection. rupture & death

2

dissection, rupture (no death)

2

dissection, death (no rupture)

5

rupture, death (no dissection)

4

rupture alone

5

dissection alone

15

cation rates. Patient characteristics are shown in Table 5 on page 29.

death alone

44

There were 178 males and 126 females. Mean age in this population

* Some patients satisfied multiple end¬
points, leading to the total of 92 specific
events

was 59.8 years and ranged from 8.8 to 93.7. Available radiologic follow-up in these patients ranged from 0
to 262 months with a median of 31.6 months. There were 28 patients with Marfan syndrome and no pa¬
tients identified with other inherited systemic connective tissue diseases. Among the 92 hard end-points
(rupture, dissection or death) realized in serial follow-up of these patients, were 55 deaths, 13 documented
ruptures and 24 new, acute aortic dissections (Table 2). We examined the mortality records of all patients.
Ten mortalities could be attributed defmitively (based on death certificates and autopsy records) to causes
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other than aortic aneurysms (for example, metastatic lung cancer or pancreatic cancer). It is likely that
some of the remaining mortality represented aneurysm rupture and that the true incidence of rupture in this
population was even higher than in our tabulation.
In contrast to most studies of the natural history thoracic aortic aneurysms, we did not limit our
analysis to patients excluded from surgery. Instead, we followed patients from diagnosis until they were
lost to follow-up or were treated surgically. Although this will lower the cumulative rates of complications
by including patients who were followed for only a single month, it provides a more accurate picture of risk
over time, and a more accurate picture of the entire population of patients with thoracic aortic disease.

Statistical Analysis
Growth Rate Analysis
Traditional methods for the estimation of aneurysm growth rates have been prone to measurement
error.62118,119 Consequently we have used the IV approach to growth rate estimation as described by Rizzo,
et al.118 "9 Specifically, we used SAS 6.12 (©1996, SAS Institute, Inc., Cary, NC) to calculate growth rate
estimates and 95% confidence intervals (Cl) for patients and sub-groups with varying risk factors. The
estimates were obtained by means of multivariable regression analysis in which aneurysm growth followed
an exponential path. In particular, the natural logarithm of the last measured size and the first measure size
was related to the time interval between the two tests and interactions between this time variable and risk
factors.
The multivariable models for aneurysm growth rates are estimated as follows:
Equation 3

r-

_ o

•e

(aTime+p Time-RISK'+dTime-RISK’)

where Sl = last size measurement, S^ = first size measurement, Time = the duration between the last and
first size measurement and RISK’ and RISK’ ’ are coefficients indicating the presence or absence of par¬
ticular risk factors being analyzed (chronic dissection, hypertension, size, etc...). Taking the natural
logarithm of each side of Equation 3 yields:
Equation 4

In .S', = In S f + a ■ Time + /3 ■ Time■ RISK'+0-Time- RISK’
Subtracting loSyfrom both sides of Equation 4 we get:
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Equation 5

In

= a • Time + (5 • Time • RISK' + 6 • 77rac • RISK"

Equation 5 is the equation we estimate for the full sample of 332 patients where RISK’ = 1 if a
dissection is present and 0 if absent. RISK’ ’ was eliminated from the overall estimation but was added for
the separate regressions described below. This equation is estimated without an intercept term because
when Time = 0, we must have 5, = Sf. The estimated regression was:
Equation 6

= 0.017791 • Time + 0.011298 • Time • RlSK\DISSECTION)
Separate regressions were estimated for ascending versus descending aneurysms, as well as for the interac¬
tion where RISK’ ’ was included as a measure of initial aortic size.
Growth rates were calculated using the above terms, starting with:
Equation 7

Growth = S[ - SjCombining Equation 3 and Equation 7 yields:
Equation 8

Growth = Sf e

(ccTime+f3-Time-RISK'+6 Time-RISK")

r.

Or:
Equation 9

Growth = Sjr(e

(ccTime+P Time-RISK'+6 Time-RISK")

-1)

Confidence intervals were obtained using the upper and lower estimates of each parameter in the regression
model.

Dr. Rizzo provided consultation in the methods of IV estimation, but all statistical analysis was

performed by the author.

Analysis of Complication Rates in Thoracic Aortic Aneurysms
Statistical methods were used to identify and estimate risk factors for the following outcomes:
cumulative incidence of major complications, survival free from major complications, and overall long¬
term survival. Results are not shown for the analyses with stratified levels because they did not provide
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Methods

All analyses were performed by the author with consultative assistance from

Dr. Rizzo.
The methods of statistical analysis included: x test f°r comparisons of dichotomous risk factors
(history of coronary artery disease, congestive heart failure, abdominal aortic aneurysm, etc...) with nega¬
tive outcomes (rupture, dissection, death), Mantel-Haenszel X test f°r comparisons taking into
consideration ranked scores of disease severity (cardiac disease, pulmonary disease, increasing aortic size,
etc...), the Wilcoxon test for one-way analysis of variance between means for comparisons between two
groups (for multiple groups, Bonferonni’s test was used). The criteria for statistical significance was p <
0.05 for all univariate tests.
Logistic regression analysis of the cumulative incidence was used to generate multivariable mod¬
els predicting increased incidence of complications. Life table estimates (Kaplan-Meier) were calculated
using the LIFETEST procedure of SAS 6.12 for PowerPC (©1996, SAS Institute, Cary, NC) with the logrank test for difference between strata. The Cox regression model (using the PHREG procedure, SAS
6.12), in a forward stepwise manner, was used to identify the most predictive variables in the analysis of
survival and complication rates over time.
Multivariable regression analyses (both logistic regression and Cox proportional hazards regres¬
sion) was performed under two models in order to assess: (1) the most conservative estimate of multivariate
predictors of rupture or dissection and (2) all factors which might (if the sample size were large enough to
demonstrate statistical significance) influence the incidence of rupture or dissection. Forward selection was
used for both, with the threshold for entry p < 0.05 for the conservative model and p < 0.70 for the other
model. Both models are reported, along with statistics describing their accuracy.

Determination of Family History and Genetic Analysis
Patient Collection and Data Analysis
Of the 668 patients described above, 60 patients had a history of Marfan syndrome, 608 patients
had no history of MFS, MFS-related disease, or any other inherited systemic connective tissue disorder.
Five patients were excluded from further analysis because their aneurysm was found to be due to congeni¬
tal disease of the aorta (eg. post-stenotic dilatation after aortic coarcatation). Of the 603 patients remaining.
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534 had confirmed TAA (171 with concomitant dissection) and 69 had aortic dissection in the absence of
TAA. Four interviewers attempted to contact 450 patients; 117 patients were lost to follow-up. Complete
medical and family histories on 278 patients (60 with MFS, 218 without—142 males and 76 females) were
obtained. All telephone screening was carried out consistently by the four trained interviewers (including
the author, who contacted 79 of the 278 patients). Responses were recorded on standardized forms. Pedi¬
gree analysis was performed on families in which more than one member had an aortic aneurysm.
We defined nMFS familial thoracic aortic disease as either aneurysm or dissection occurring in
patients with 1 or more first-degree relatives with aneurysm or dissection and no history of MFS or other
inherited systemic connective tissue defect. For the purposes of this study, patients with family members
known to have AAA or cerebral aneurysms were included in the family history group. This was done, in
part, because some families with multiple individuals affected by TAA also had family members with AAA
or cerebral aneurysms, suggesting a possible connection between these forms of aneurysmal disease. We
defined sporadic cases as those occurring in patients with no family history of aortic disease and no history
of Marfan syndrome or any other inherited systemic connective tissue defect. Patients with a family history
of sudden death (although included in other studies of familial risk of aneurysmal disease)107 were not con¬
sidered to have a family history and were included with the sporadic cases. Patients with a diagnosis of
Marfan syndrome met the revised criteria for the diagnosis as outlined by DePaepe, et al.90
Statistical methods were used to compare the 3 categories of aortic disease: nMFS familial, spo¬
radic, and MFS-associated. Separate analysis was carried out for the 3 categories of patients, additionally
those patients in whom a positive or negative family history was obtained were compared to the 344 pa¬
tients for whom family history was not known, in order to assess the impact of the patient collection
method. All statistical analysis was performed by the author.
Serial follow-up was available for 41 patients in the familial non-syndromic group, 174 patients in
the sporadic group, and 47 patients in the MFS group. Mean follow-up time for the 3 categories was 49.6
months (median 33.3, range 0.0 to 317.7 months) for patients with familial non-syndromic TAA, 43.9
months (median 31.8, range 0.0 to 224.2 months) for sporadic TAA, and 101.9 months (median 91.3, range
0.0 to 415.5 months) for patients with MFS. As described above, subsets of patients were used for the
various analyses. When growth rates were calculated, the exclusion criteria detailed under Growth Rates
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on page 21 were used. Sample sizes were not sufficient to perform separate complication rate analyses for
each group: sporadic, familial-nMFS, and MFS-related, nor were they sufficient to use the presence of a
family history as a risk factor for the analysis of complication rates.

Genetic Analysis
Patients identified as having a non-syndromic family history were contacted and blood samples
were collected after appropriate informed consent was signed. Blood samples were provided to the labo¬
ratory of Richard P. Lifton, MD, PhD, in the Department of Genetics and the Howard Hughes Medical
Institute. Personnel in the laboratory performed the following work:
Genomic DNA was obtained from whole blood samples by standard procedures.120 Genotyping of
a total of 6 polymorphic loci spanning a region surrounding FBN1 was performed by PCR with a custom¬
ized set of primers in a single collected family. PCR products were labeled by incorporation of fluorescent
end-labeling of oligonucleotide primers with analysis performed on an ABI 377 instrument equipped with
GENESCAN 2.1 and GENOTYPER 1.1.1 software (Applied Biosystems). Genotypes were scored by a
single investigator blinded to infection status. Marker order was obtained from databases at the Whitehead
Institute for Biomedical Research/MTT Center for Genome Research, The Cooperative Human Linkage
Center, and The Genome Database, and analysis of linkage was performed by use of the GENEHUNTER
program121 on a SUN SparcStation.
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RESULTS

Characteristics of the Entire
Study Population

Table 3. Demographic characteristics of 668 patients with thoracic aortic disease

Demographic characteristics and
the incidence of risk factors for the entire
study population are given in Table 3.
The male:femalc ratio was 1.6:1. Other
comorbidities—especially vascular co¬
morbidities—abounded. In particular,
347 patients (63.6%) had a history of

Variable

N

%

Sex (male)

414

62.0 %

Mean

Median

Range

Age at presentation (yrs)

604

60.4

67.1

7 days to
95.2 years

Aortic diameter at presentation (cm)

488

5.0

4.7

3.5 to 11.0

Hypertension (n = 546)

347

63.6%

Cardiac Diseasefn = 496)

196

39.5 %

Pulmonary Disease (n = 512)

98

19.1 %

Renal Disease (n = 496)

56

11.3 %

Carotid Disease (n = 472)

61

12.9 %

Tobacco Use(n = 492)

193

39.2 %

CAD

159

23.7 %

CHF

63

9.4%

CVA/TIA

53

7.9 %

AAA

80

12.0 %

Marfan syndrome

60

9 .0 %

hypertension. There were 30 patients
(12.0%) with a history of AAA (defined as a previously diagnosed, but not necessarily repaired abdominal
aortic aneurysm).

Aneurysm Growth Rates
Aneurysm growth rates were calculated as described earlier. Table 4 shows the average growth
rate according to initial aneurysm size and risk factor status.

Aneurysms in the descending or thoraco¬

abdominal region had substantially
n Ascending/Arch

higher growth rates (0.19 cm/yr) than

□ Descending/Thoracoabdominal

-♦-All

0.35

those in the ascending aorta or aortic

0.30

arch (0.07 cm/yr). This information

_ 0.25

is presented graphically in Figure 15.

!°.20

>*

1 0.15

A similar difference in growth rates

o

O

0.10

was found with dissected (0 14
0.05

cm/yr) versus non-dissected (0.09

0.00
3.5- 3.9

cm/yr) aortas. Patients with Marfan
syndrome and those with a history of

4.0 -4.9

5.0 - 5.9

6.0 - 6.9

All

Initial Aneurysm Size

Figu re 15. Multivariable estimates of aneurysm growth rates by initial aortic size and location.
The blue bar indicates the growth rates of descending and thoraco-abdominal aneurysms, the
white bar rates for ascending/arch aneurysms. The red line is the average for aneurysms inde¬
pendent of location.
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Table 4. Multivariate estimates of aneurysm growth rates.*
Annual growth rate (cmjyr) according to initial aneurysm sizef
Patient Category
All (n = 332)

<4.0

4.0-4.9

5.0-5.9

> 6.0

All

0.14 cm/yr

0.09 cm/yr

0.08 cm/yr

0.16 cm/yr

0.10 cm/yr

(0.04 to 0.23)

(0.02 to 0.16)

(-0.01 to 0.16)

(0.00 to 0.32)

(0.08 to 0.13)

Location of Aneurysm
Ascending or arch (n = 214)

Descending or thoraco-abdominal (n = 118)

0.13 cm/yr

0.07 cm/yr

0.02 cm/yr

0.08 cm/yr

0.07 cm/yr

(-0.02 to 0.28)

(-0.05 to 0.20)

(-0.06 to 0.18)

(-0.13 to 0.37)

(-0.03 to 0.16)

0.24 cm/yr

0.20 cm/yr

0.19 cm/yr

0.32 cm/yr

0.19 cm/yr

(0.10 to 0.37)

(0.08 to 0.32)

(0.05 to 0.33)

(0.09 to 0.55)

(0.11 to 0.26)

Comorbidities
Hypertension (n = 186)

Pulmonary Disease (n = 47)

History of Coronary Artery Disease (n = 95)

Marfan Syndrome (n = 42)

AAA (n = 46)

0.14 cm/yr

0.09 cm/yr

0.07 cm/yr

0.15 cm/yr

0.09 cm/yr

(0.0 to 0.30)

(-0.04 to 0.21)

(-0.08 to 0.22)

(-0.08 to 0.40)

(0.01 to 0.17)

0.20 cm/yr

0.13 cm/yr

0.14 cm/yr

0.18 cm/yr

0.13 cm/yr

(0.04 to 0.36)

(0.0 to 0.27)

(-0.03 to 0.31)

(-0.06 to 0.43)

(0.04 to 0.21)

0.13 cm/yr

0.08 cm/yr

0.07 cm/yr

0.11 cm/yr

0.07 cm/yr

(-0.01 to 0.27)

(-0.04 to 0.20)

(-0.08 to 0.22)

(-0.11 to 0.35)

(0.00 to 0,15)

0.14 cm/yr

0.11 cm/yr

0.10 cm/yr

0.20 cm/yr

0.13 cm/yr

(0.01 to 0.29)

(-0.01 to 0.24)

(-0.04 to 0.25)

(-0.02 to 0.44)

(0.05 to 0.20)

009 cm/yr

0.04 cm/yr

0.01 cm/yr

0.07 cm/yr

0.04 cm/yr

(-0.06 to 0.24)

(-0.09 to 0.18)

(-0.15 to 0.17)

(-0.16 to 0.32)

(-0.05 to 0.13)

Chronic Dissection
Present(n = 119)

Absent (n = 93)

0.17 cm/yr

0.12 cm/yr

0.12 cm/yr

0.21 cm/yr

0.13 cm/yr

(0.04 to 0.31)

(0.01 to 0.21)

(-0.03 to 0.26)

(-0.02 to 0.44)

(0.05 to 0.20)

0.13 cm/yr

0.07 cm/yr

0.06 cm/yr

0.14 cm/yr

0.08 cm/yr

(0.03 to 0.23)

(0.00 to 0.11)

(-0.03 to 0.15)

(-0.03 to 0.30)

(0 .06 to 0.11)

t Values indicate aortic growth rate based on regression analysis for patients with serial imaging studies. The regression model used to calculate
each value includes the variables indicated in the row and column headings, as well as the time between studies. 95% confidence intervals are given
in parentheses.

pulmonary disease also had higher growth rates. Growth rate differences between ascending and descend¬
ing and dissected and nondissected aneurysms per¬
All Locations

sisted when we controlled

□ Ascending

for initial aortic size. Al-

oArch

□ Descending

is Thoraco-abdominal

— 133

though the differences in
growth rates were strong
trends, the sample sizes
were not large enough to
assess statistical signifi¬
cance.
3.5 -3 9

4.0 -4.9
5.0 - 5.9
Initial Aneurysm Size (cm)

>

6.0

Figure 16. Histogram of initial aortic size and aneurysm location.
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Analysis of complications
Demographic and Clinical Characteristics of the Study Population
Demographic characteristics and the prevalence

Table 5. Demographic information on 304 patients included m
analysis of complications.*

of risk factors for the 304 patients included in the analysis of complication rates are given in Table 5. In this
population, 142 patients (39.1%) had a history of hyper-

Variable

Mean

Initial aortic size (cm)

5.0

Radiologic follow-up (mths)

43.1

0.0 to 262.6

Age at presentation (yrs)

59.8

8.8 to 93.7

Variable
Sex (male)

tension. Again, the prevalence of vascular comorbidities

Marfan syndrome

Range
3.5 to 11.0

N

%

178

58,9 %

28

9.2 %

Aneurysm Size

was particularly high. The distribution of aneurysms by
initial size is shown in Figure 17 and Figure 16. Aneu-

3.5 to 3.9 cm

33

10.9 %

4.0 to 4 .9 cm

133

43.8 %

5.0 to 5.9 cm
2

rysms of the ascending aorta were substantially more

6.0 cm

for each aneurysm location is shown in Table 6. Aneu-

initial sizes than those in the descending or thoracoabdominal region (p

=

0.0001)

19.7 %

219

72.0 %

Arch

18

5.9 %

Descending

28

9.2 %

Thoracoabdominal

39

12.8%

Hypertension (n = 225)

rysms of the ascending aorta and aortic arch had smaller

25.7 %

Aneurysm Location
Ascending

common than the others. The mean initial aortic size

78
60

Cardiac Disease (n = 219)

142

59.1 %

96

43.8 %

Tobacco Use (n= 220)

81

36.8 %

Pulmonary Disease (n = 225)

47

20.9 %

Carotid Disease (n = 209)

23

11.0 %

Renal Disease (n = 220)

30

13.6%

CAD (n = 304)

82

24.6 %

CHF (n = 304)

34

10.2 %

CVA (n =304)

25

7.5 %

AAA (n = 304)

31

9.3 %

* percentages may not sum to 100 due to rounding.
AAA = abdominal aortic aneurysm, CAD = coronary artery
disease, CHF = congestive heart failure, CVA = cerebrovascular
accident

140

Initial aortic size (cm)
Figure 17. Histogram of initial aortic size in 304 patients.
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Table 6. Initial aortic size (cm) in 304 patients with thoracic aortic aneurysms.
Non Marfan syndrome (n = 276)

Marfan syndrome (n = 28)*

Mean

Range

Mean

Range

Ascending (n = 219)

4.8t

3.5 to 10.5

4.5

3.5 to 7.0

Arch (n =18)

5.9t

4.0 to 11.0

N/A

N/A

Descending (n = 28)

5.3

3.5 to 7.5

N/A

Thoraco-Abdominal (n = 39)

5.7f

3.8 to 9.8

8.3

8.3 to 8.3

Ascending/arch (n = 237)

4.9+

3 .5 to 11.0

4.5

3.5 to 7.0

Descending/thoracoabdominal (n = 67)

5.5+

3.5 to 9.8

8.3

8.3 to 8.3

ALL PATIENTS (n = 304)

5.If*

4.6*

* Differences between patients with Marfan syndrome and those without were not statistically significant at p s 0.05
t p < 0.005 for the comparison of initial aortic size in ascending versus arch or thoracoabdominal, Bonterroni's test
X p = 0.0001, Wilcoxon test.

Complication Rates

Cumulative Incidence
Figure 18 illustrates the cumulative incidence of rupture and dissection during follow-up stratified
by initial aortic size. The incidence increases with increasing aortic size (p = 0.0003). Patients with the
largest aneurysms (a 6.0 cm) had complication rates more than seven times as high as those with the small¬
est aneurysms (< 4.0 cm) (21.7% versus 3%). Similar increases were observed for rupture alone (p =
0.0006) and acute dissection alone (p = NS), as shown in Figure 19 and Figure 20.

150

120

.------------------------.-.-r

-

3.5 to 3.9

4.0 to 4.9
5.0 to 5.9
Initial aortic size (cm)

6.0 to 6.9

Figure 18. Incidence of acute dissection or rapture as a function of initial aneurysm size. The entire column indicates the total number of patients with
thoracic aortic aneurysms in each size range

The black area indicates the number of patients who incurred an acute dissection or rapture of the aneurysm.

The line graph and associated percentages indicates the percentage of patients in each category who incurred an acute dissection or rapture of the aneurysm
and corresponds to the axis on the right.
t Statistically significant increase in complication rates with increasing initial aortic size,p = 0.003. (Mantel-Haenszel'// test)
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Figure 19. Incidence of rupture as a function of initial aneurysm size

The entire column indicates the total number of patients with thoracic aortic

aneurysms in each size range. The black area indicates the number of patients who incurred a rupture of the aneurysm. The line graph and associated
percentages indicates the percentage of patients in each category who incurred a rupture of the aneurysm and corresponds to the axis on the right,
t Statistically significant increase in complication rates with increasing initial aortic size,p = 0.006. (Mantel-Haenszel x2 test)

3.5 to 3.9

4.0 to 4.9

5.0 to 5.9

6.0 to 6.9

Initial aortic size (cm)
Figure 20. Incidence of acute dissection as a function of initial aneurysm size. The entire column indicates the total number of patients with tho¬
racic aortic aneurysms in each size range. The black area indicates the number of patients who incurred an acute dissection of the aneurysm. The
line graph and associated percentages indicates the percentage of patients in each category who incurred an acute dissection of the aneurysm and cor¬
responds to the axis on the right.
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Table 7. Aneurysm size (cm) at the time of complication.
All Patients

All ruptures or
acute dissections

Mean'

Median

5.7 cm

5.5

Non Marfan syndrome (n

=

28)

Marfan syndrome (n

=

5)

Range

Mean'

Median

Range

Mean

Median

Range

4.0 to 9.3

5.8

5.8

4.0 to 9.3

52 cm

4.4

42 to 8.3

42 cm

42

42 to4.2

5.9 cm

5.0

4.4 to 8.3

4.3

4.2 to 5.0

8.3

8.3 to 8.3

(3.0 to 7.4)

(53 to 6.3)

(52 to 6.2)

(n = 33)
All dissections

4.6 cm

(n = 24)t

(5.1 to 6.1)

All ruptures

5.9 cm

(n = 13)t

5.4
5.8

5.7 cm

Descending/

5.9 cm

thoracoabdominal

5.9

4.0 to 9.3

4.0 to 8.0

5.9

4.0 to 9.3

(4.8 to 7.0)
5.2

5.9 cm

4.0 to 9.3

(0.68 to 11.2)
5.8

4.0 to 9.3

(52 to 6.8)

(5.0 to 6.3)

(n = 22)

5.7

(52 to 62)

(5.0 to 6.9)

Ascending /arch

5.7

4.0 to 8.0

6.0

5.6 cm

4.0 to 8.3

(5.0 to 6.7)

4.5 cm
(3.8 to 5.1)

5.8

4.0 to 7.2

8.3 cm

(4.9 to 6.4)

(n = 11)

*95% Confidence intervals for the mean are given in parentheses
tThe sum of all acute dissections and all ruptures is more than 33 because some patients incurred both acute dissections and ruptures.

The mean and median thoracic aortic sizes at the time of rupture or dissection are shown in Table 7.
Mean size at dissection was 4.6 cm, while the mean size at rupture was 5.9 cm. Sample sizes were not ade¬
quate to demonstrate statistical significance, but trends suggest that complications occur at larger aortic
sizes in the descending and thoracoabdominal aorta versus the ascending aorta, and at smaller sizes in pa¬
tients with Marfan syndrome than in those without.
Univariate analysis of risk factors predictive of rupture and dissection is shown in the top of
Table 8. Initial aortic size a 6.0 cm was associated with a nearly four-fold increase in the incidence of
rupture. Other significant univariate predictors of rupture included location of the aneurysm in the de¬
scending or thoraco-abdominal aorta and a history of abdominal aortic aneurysm. In addition, male gender
conferred significant protection from rupture. The bottom of Table 9 shows risk factors for dissection. A
history of coronary artery disease was the only statistically significant univariate predictor of dissection.
The incidence of rupture and dissection was analyzed together at the top of Table 9. Size was a
powerful predictor of these complications. The protective effect of male gender was consistent, as was the
increased risk associated with the presence of other vascular diseases including coronary artery disease,
abdominal aortic aneurysm, or a history of stroke. The bottom of Table 9 also indicates that nearly all co¬
morbidities, but particularly vascular diseases, were associated with an increased incidence of death prior to
surgical correction in this population. Increasing aortic size showed a trend toward increased preoperative
mortality with an odds ratio of 1.911.
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Table 8. Univariate analysis of risk factors predictive of rupture or dissection.

Risk Factor

Complication Rate

Odds Ratio

Odds Ratio

P value

(with 95% CD
Risk Factors for Rupture

Initial Aortic Size

3.5 to 3.9 cm

0/33 (0.0%)

5.0 to 5.9 cm

4/78(5.1%)

> 6.0 cm

6/60(10.0%)

i
i

0.198

i
i
i

1.303

m
■

I
i

3.762f

Gender (male)

6/96 (3.1%)

Marfan syndrome

4/35 (11.4%)

Aneurysm location (desc/TA)

6/66 (9.1%)

0.365f
2.839
3.243f

Hypertension

12/162 (9.1%)

2.100

Cardiac Disease

8/104 (7.7%)

1.396

Tobacco History

5/86 (5.8%)

0.761

Pulmonary Disease

3/51 (5.9%)

0.909

Carotid Disease

2/28 (7.1%)

1.250

Renal Disease

2/35 (5.7%)

0.928

CAD

7/82 (8.5%)

2.259

CHF

0/34 (0.0%)

Prior CVA

3/25 (12.0%)

2.873

AAA

5/31 (16.1%)

4.663f

0.014t

0.044f

1
■
■

L

r

i
i
i
i

1

1_
1

i
i
i
i

1

0.201
0.518

1
1
1

0.623

m
"

1
1

0.085

■
"

|
1

0.778

1

■
■

1
1

1
1

L.

0.924

m
■

r

i
i
i
i

0.032+

1
1

"

"

1
1

i
i
i
i
i

0.071
'

"
■
"

l
1

i

1
1

|
i

0.102
0.154

■

L

r

i
i
i
i
i

0 IfP
■
■

1
i

i

|

o nnif

i
i
i
i

Risk Factors for Dissection
3.5 to 3.9 cm
Initial Aortic Size

'
i

.ii
"1

■

1

i
i
i

0.666

1
1

5.0 to 5 9 cm

i/jJ

g

/o)

6/78 (7.7%)

0.963

> 6.0 cm

8/60(13.3%)

Gender (male)

13/196 (6.6%)

0.542

Marfan syndrome

2/35 (5.7%)

0.611

Aneurysm location (desc/TA)

6/66 (9.1%)

Hypertension

18/162 (11.1%)

1.200
1.936

Caidiac Disease

13/104(12.5%)

1.418

Tobacco History

10/91 (11.0%)

1.073

i
i
i
i
i
i

0.615

i
>
,

Renal Disease

3/35 (8.6%)

0.810

i
j

CAD

7/82 (8.5%)

2.370t

AAA

4/31 (12.9%)

1.647
Odds Ratio

|

1
l

i
i
,
i
i

i
0.1

0.081

i
|
i

1
1

0.510

■

0.711

i

L

"
1
i

■
"

1
1

1
1

■
"

1

0.416

1

■
■

L
1

i
i
i
i
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t = Statistically significant results. Bars on graph indicate 95% confidence intervals, odds ratios cannot be calculated when the incidence of the
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accident or stroke, desc = descending, TA = thoraco-abdominal.
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Table 9. Univariate analysis of risk factors predictive of rupture or dissection and death.

Risk Factor

Complication Rate

Odds Ratio

Odds Ratio

P value

(with 95% Cl)

Risk Factors for Rupture or Dissection

Initial Aortic Size

3.5 to 3.9 cm

1/33 (3.0%)

0.233

0.126

5.0 to 5.9 cm

8/78 (10.3%)

0.919

0.844

13/60 (21.7%)

3.098

0.003f

17/196(8.7%)

0.475

0.0271

6.0 cm

Gender (male)
Marfan syndrome

6/35 (17.1%)

1.613

0.472

Aneurysm location (desc/TA)

11/66(16.7%)

1.927

0.096

Hypertension 25/162 (15.4%)

1.626

0.204

Cardiac Disease 17/104(16.3%)

1.265

0.516

Tobacco History

13/91 (14.3%)

0.957

0.906

Pulmonary Disease

6/51 (11.8%)

0.764

0.573

Carotid Disease

4/28(14.3%)

0.983

0.977

Renal Disease

4/35 (11.4%)

0.753

0.616

CAD

16/82(19.5%)

2.303

0.016f

CHF

2/34(5.9%)

0.431

0.248

Prior CVA

6/25 (24.0%)

2.554

0.054

AAA

7/31 (22.6%)

2.386

0.056

Risk Factors for Mortality
3.5 to 3.9 cm
Initial Aortic Size

3/33 (9.1%)

0.421

;

0.679

i
1

16/60 (26.7%)

1.911

1
1
l

Gender (male)

24/196(12.2%)

0.367

Marfan syndrome

2/35 (5.7%)

0.241

5.0 to 5.9 cm
6.0 cm

11/78 (14.1%)

1
1
l

20/66 (30.3%)

2.472

35/162 (21.6%)

2.035

1

2.206

18/91 (19.8%)

1.491

Pulmonary Disease

15/41 (36.6%)

2.486

Carotid Disease

10/28 (35.7%)

3.278

Renal Disease

12/35 (34.3%)

3.165

CAD

17/82 (20.7%)

1.203

CHF

12/34(35.3%)

2.727

Prior CVA

9/25 (36.0%)

2.717

AAA

11/31 (35.5%)

2.718
Odds Ratio

1

-1
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0
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t = Statistically significant results. Bars on graph indicate 95% confidence intervals, odds ratios cannot be calculated when the incidence of the measured
outcome is zero. AAA = abdominal aortic aneurysm, CAD = coronary artery disease, CHF = congestive heart failure, CVA = cerebrovascular accident or
stroke, desc = descending, TA = thoraco-abdominal.
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The results of a

Table 10. Logistic regression of risk factors for rupture or dissection (dependent variables)§
Regression Analysis

multivariable regression

Conservative Model
Parameter estimate

Variable

Entry at
Standard error

p < 0J0S*
p Value

Intercept term

-22261

0.2476

0.0001

Aortic Size

1.0557}

0.4234

0.0126}

Odds Ratio f

analysis examining risk
2

6.0 cm}

factors predictive of rupture
Regression Analysis

or dissection prior to surgi¬

Variable

Intercept term

cal correction are given in

Liberal Model
Parameter estimate
-22261

Entry at
Standard error

2.874}

(1253 - 6589)

p < 0.7**
p Value

02476

0.0001

Odds Ratio t

Aortic Size

Table 10. The only risk

< 4.0 cm

-0.9107

1.0884

0.4027

0.402

(0.048-3.396)

5.0 - 5.9 cm

0.2362

05341

0.6583

1266

(0.445 - 3.607)

6.0 cm}

1.0994}

05127

0.0320}

3.002}

(1.099-8.201)

-0.00757

0.0122

05335

0.992

(0.969-1.016)

2

factor remaining in the
model following stringent

Age at presentation
(risk per year)
AAA

0.4769

05818

0.4123

1.611

(0515 - 5.039)

selection criteria (p s 0.05)

CAD

0.7283

0.4548

0.1093

2.071

(0.850-5.051)

CHF

-0.9483

0.7786

02233

0387

(0.084- 1.782)

was aneurysm size a 6.0
cm. At that size, the risk of
incurring a rupture or dis-

§ This variable equals 1 if the patient incurred a rupture or acute dissection and 0 otherwise.
•Criteria for assessing model fit: -2 Log L: intercept only: 176.919; intercept and covariates: 171.147;
for
covariates: 6.629 with 1 DF (p = 0.001).
••Criteria for assessing model fit: -2 Log L: intercept only: 176.919; intercept and covariates: 164.400; x2 for
covariates: 12.826 with 7 DF (p =0.0765).
t 95% confidence intervals on odds ratios are given in parentheses.
} Statistically significant at p < 0.05 level.

section was nearly three
times as high as for aneurysms of 4.0 to 4.9 cm. When a less stringent selection criteria (p < 0.70) was
used, the model again demonstrates the importance of vascular comorbidities in predicting rupture or dis¬
section in this population. Table 10 indicates that the odds of incurring a rupture or acute dissection are
2.0 times greater (95% Cl 0.515 to 5.039) for patients with coronary artery disease, and 1.6 times greater
(95% Cl 0.850 to 5.5051) for those with a history of abdominal aortic aneurysm.
Incidence of Rupture, Dissection and Death Over Time
The incidence of rupture or dissection over time as a function of initial aneurysm size is given in
Figure 21. The rate of ruptures and dissections was significantly higher in patients with higher initial aor¬
tic size {p = 0.006). At aortic sizes a 6.0 cm, there is a marked step-up in the average yearly rate of
complications to 6.9% per year (Figure 22). Proportional hazards regression demonstrates that the hazard
function is more than 2.7 times worse for patients with size 26.O cm than for those with size between 4.0 to
4.9 cm, again male sex confers some relative protection from adverse events (Table 11). When less strin¬
gent criteria are used to create a proportional hazards model, the importance of size can clearly be seen, in
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Table 11. Proportional hazards regression of factors predicting increased rates of rupture or dissection, (dependent variables)§
Regression Analysis

Conservative Model

Variable

Parameter estimate

Size

2

6.0 cmt

Gender (male)t

Entry at
Standard error

p < 0.05*
p Value

Odds Ratiof

1.0023 36f

0.38378

0.0090f

2.725f

(1.284 - 5.781)

-0.904492ft

0.39089

0.0207ft

0.405ft

(0.188 -0.871)

Regression Analysis

Liberal Model

Variable

Parameter estimate

Entry at
Standard error

p < 0.70**
p Value

Odds Ratiof

Initial Aortic Size
3.5 - 3.9 cm

-0.429173

1.06710

0.6875

0651

(0.080- 5.271)

5.0 - 5.9 cm

0.815989

0.51781

0.1151

2.261

0.820 - 6.239

1.489282+

0.49997

0.0029f

4.434f

(1.664- 11.813)

Location (Desc/TA)

-0.202180

0.44746

0.6514

0.817

(0.340- 1.964)

Gender (male)f

-1.010436ft

0.41804

0.0156ft

0.364ft

(0.160-0.826)

Pulmonary Disease

-0.220534

0.53700

0.3242

0.802

(0.471 - 1.365)

AAA

0.529420

0.21731

0.5594

1.698

(0.593-4.864)

HTN

-0.126842

0.18055

0.1457

0.881

(0.575- 1.349)

Cardiac Disease

0.262694

0.27112

0.4160

1.300

(0.913- 1.853)

2

6.0 cmt

§ This variable equals 1 if the patient incurred a rupture or dissection and 0 otherwise.
♦Criteria for assessing model fit: -2 Log L: without covariates: 274.596; with covariates: 262.811; x* for covariates: 11.785 with 2 DF (p =
0.0028).
** Criteria for assessing model fit: -2 Log L: without covariates: 274.596; with covanates: 256.536; y2 for covariates: 18.060 with 9 DF (p
=0.0345).
t 95% confidence intervals on odds ratios are given in parentheses,
f Statistically significant at the 1% level,
ft Statistically significant at the 5% level.

Figure 21. Kaplan-Meier cumulative incidence of rupture or dissection. Five-year hazard estimates are illustrated for patients as a function
of initial aneurysms size, p = 0.006.

Figure 22. Average yearly rate of rupture or dissection by initial
aortic size,

addition, a history of hypertension or pulmonary disease both show a trend toward increasing rates of rup¬
ture or dissection (risk ratios: 1.300 and 1.698,p = 0.14 and 0.32, respectively).
The importance of size is vividly apparent when rupture is analyzed alone (Figure 23 and Figure
24). Under the most conservative proportional hazards model the rate of rupture is five times worse with
aortic size of 5.0 to 5.9 cm and nearly ten times worse with size a 6.0 cm when each is compared with an¬
eurysms of size < 4.0 cm (Table 12). Under the less conservative model, size has an even greater impact.
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Table 12. Proportional hazards regression of factors predicting increased rates of rupture (dependent variables).§
Entry at

p < 0.05*

Regression Analysis

Conservative Model

Variable

Parameter estimate

Standard error

p Value

5.0 - 5.9 cm

1.595365

0.86744

0.0659

4,930

(0.901 -26.991)

6.0 cm*

2.256365*

0.81758

0.0058*

9.548*

(1.923 - 47.408)

Odds Ratiof

Initial Aortic Size

2

Regression Analysis

Liberal Model

Variable

Parameter estimate

Entry at

p < 0.70**

Standard error

p Value

Odds Ratiof

Initial Aortic Size
3.5 - 3.9 cm

-13.536449

1554

0.9930

0.000

(N/A)

5.0 - 5.9 emtt

1,984684ft

0.99127

0.0453ft

7.277ft

(1.043 -50.782)

2.715466*

0.94503

0.0041*

15.112*

(2.371 -96.321)

Gender (male)f f

-1.487251ft

0.72427

00400ft

0.226ft

(0.055 -0.935)

Age at presentation (risk/year)

-0.012866

0.01927

0.5044

0.987

(0.951

AAA

0.531282

0.71240

0.4558

1.701

(0.421 -6.873)

HTN

-0.565626

0.42697

0.1853

0.568

(0.246

Cardiac Disease

0.552271

0.29030

0.0571

1.737

(0.983 -3.069)

2

6.0 cm*

1.025)

1.312)

§ This variable equals 1 if the patient incurred a rupture andO otherwise.
* Criteria for assessing model fit: -2 Log L: without covariates: 112.877: with covariates: 103.063; x2 for covariates: 9.814 with 2 DF
(p = 0.0074).
** Criteria for assessing model fit: -2 Log L: without covariates: 112.877; with covariates: 93.424; x2 for covariates: 19.453 with 7
DF (p =0.0069).
t 95% confidence intervals on odds ratios are given in parentheses.
*Statically significant at the 1% level,
ft Statistically significant at the 5% level.
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20%
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Figure 24. Kaplan-Meier cumulative incidence of rupture. Five-year
hazard estimates are illustrated for patients as a function of initial
aneurysm size, p = 0.0045.

0.0%
Figure 23. Average yearly rate of rupture by initial aortic size. In this graph
and those on succeeding pages, the colors consistently indicate the same
size: blue = 3.5 to 3.9 cm, green = 4.0 to 4.9 cm, yellow = 5.0 to 5.9 cm, and
red = a 6.0 cm

and other important risk factors predictive of worse outcomes become visible, including a history of ab¬
dominal aortic aneurysm and a history of cardiac disease. Male gender again confers a relative protective
effect (p = 0.04). Similar risk with increased aortic size is seen when dissection is analyzed alone (Figure
25 and Figure 26).
As described above, nearly all risk factors were predictive of increased risk of death prior to op¬
eration in a univariate analysis (Table 9). Flowever, when analyzing the survival of these patients prior to
operative repair with proportional hazards, only a history of abdominal aortic aneurysm (risk ratio 2.218,
95% Cl 0.985 to 4.597) and increasing age at presentation (risk ratio 1.072 per year, 95% Cl 1.038 to
1.106) were predictive of poor survival (data not shown). Increasing aortic size was associated with de-

37

Results

Davies et al. - The Natural History of Thoracic Aortic Disease

50%
45% •

1

o
o
to

Initial aortic size (cm)
6.9

40%
35%

5.0 to 5.9

30%

— 4.0 to 4.9

25%

j

20%

-

3.5 to 3.9

15%
10%
5%
0%
0

12

3

4

5

Years

Figure 25. Kaplan-Meier cumulative incidence of dissection. Five-

Figure 26. Average yearly rate of dissection by initial aortic size,

year hazard estimates are illustrated for patients as a function of initial
aneurysms size,/? = 0.1878.

Figure 27. Kaplan-Meier cumulative survival prior to operative re¬

Figure 28. Average yearly rate of death by initial aortic size.

pair. Five-year survival estimates are illustrated for patients as a
function of initial aneurysm size,/? = 0.0671.

creasing survival (p = 0.067) (Figure 27). The
yearly rates demonstrate dramatic increases at
sizes a 6.0 cm (Figure 28).
This step-up in the risk is clearly evident
when rupture, dissection and death prior to surgical
repair are considered as endpoints together (Figure
29), with a mean yearly rate twice as high in pa¬
tients with size greater than 6 cm than in those
with smaller aneurysms. Proportional hazards
regression of this combined end-point confirmed

Figure 29. Average yearly rate of rupture, dissection or death
based on initial aortic size
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Table 13. Proportional hazards regression of factors predicting increased rates of complications (rupture, dissection or death)
pri' >r lo^ircervuiqn-nden! v.in.iMes) 1;

___
Entry at

Regression Analysis

Conservative Model

Variable

Parameter estimate

Standard error

p Value

Size

0.589408tt

0.28672

0.0398ft

1.803ft

(1.028 - 3.163)

Age at presentation (risk/year)t

0.0345161

0.00908

0.000 If

1.035f

(1.017- 1.054)

Regression Analysis

Liberal Model

2

6.0 emtt

Entry at

p < 0.05*
Odds Ratio f

p<0.70**

Variable

Parameter estimate

Standard error

p Value

Size

0.624428ft

0.31478

0.0473tf

1,867ft

(1.007 - 3.460)

Location (Desc/TA)

-0.263983

0.31120

0.3963

0.768

(0.417

Gender (male)

-0.367578

0.28381

0.1953

0.692

(0.397 - 1.208)

Age at presentation (risk/year)f

0.0282691

0.00969

0.0035f

1.029f

(1.009

1.048)

AAA

0.555504

0.36834

0.1315

1.743

(0.847

3.587)

Pulmonary Disease

0.233892

0.33102

0.4798

1.264

(0.660

2.417)

Cardiac Disease

0.226279

0.28009

0.4192

1.254

(0.724- 2.171)

2

6.0 cmft

Odds Raliof

1.413)

§ This variable equals 1 if the patient ruptured, dissected or died prior to surgical correction and 0 otherwise.
‘Criteria for assessing model fit: -2 Log L: without covariates: 522 .849; with covariates. 496.325; yl for covariates: 26.524 with
2 DF (p = 0.0001).
** Criteria for assessing model fit: -2 Log L: without covariates: 522.849; with covariates: 490.231; y2 for covariates: 32 .618
with 7 DF(p =0.0001).
t 95% confidence intervals on odds ratios are given in parentheses
fStatistically significant at the 1% level
ft Statistically significant at the 5% level.

the impact of larger aortic size on

□ 3.5 to 3.9 cm

a 4.0 to 4.9 cm

□ 5.0 to 5.9 cm

H > 6 0 cm

16%

poor outcome prior to surgical
correction (Table 13). Patients

14.1%

12%

with aneurysms of the descending
8%

or thoraco-abdominal aorta were
less likely to rupture (odds ratio

4%

0.768,95% Cl 0.417 to 1.413) in
this model, but otherwise the

0%
Rupture

Dissection

Rupture or
Dissection

model contained similar predic-

Death

Rupture,
Dissection or
Death

tors of complications as
Figure 30. Average yearly rates of all negative outcomes by initial aortic size.

previously described. The yearly
rates for all endpoints are summarized graphically in Figure 30.
Long-Term Survival
Overall long-term survival for all patients, independent of surgical correction, as a function of ini¬
tial aortic size is shown in Figure 31. Larger aneurysms arc associated with decreased long-term survival
[p = 0.0039). Five-year survival in patients with aneurysms a 6.0 cm is only 56%. Overall, for all patients

in the database, survival was better for the ascending than for the descending aorta (Figure 32), which may
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reflect the larger size of descending aneurysms at
presentation (Figure 16 and Table 6) and higher
growth rates (Table 4). Survival was also better for
non-dissectcd than for dissected aortas (Figure 33).
Long-term survival is better in patients treated with
elective surgery than in those who require emergent
surgery or those maintained on medical therapy
Figure 31. Kaplan-Meier cumulative survival. Five-year survival

(Figure 34).

Postoperative survival for patients

estimates are illustrated for patients as a function of initial aortic size.p
= 0.0671

treated emergently remains poor in this population
when compared to those treated electively (Figure 35).
Elective surgery restores a flat survival curve indistinguishable from that of the normal population.

Figure 32. Kaplan-Meier cumulative survival. Five-year survival esti¬

Figure 33. Kaplan-Meier cumulative survival. Five-year survival esti¬

mates are illustrated for patients as a function of aneurysm location,p =
0.0023.

0.0002.

mates are illustrated for patients as a function dissection status,p =

Figure 34. Kaplan-Meier cumulative survival. Five-year survival

Figure 35. Kaplan-Meier cumulative survival. Five-year post¬

estimates are illustrated for patients as a function of the treatment
received, p =0.002.

operative survival estimates are illustrated for patients as a function of
the urgency of the surgical procedure,p = 0.0004
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The Impact of Genetic Factors on Natural History
Demographic and Clinical Characteristics of the Study Population

Table 11 indicates the baseline charac¬

Table 14. Comparison of demographic characteristics in patients between
patients with known (+ or -) family history and those with unknown family
history. (Numbers are percentages unless otherwise indicated)
Known

teristics in the 218 patients without MFS for

(n

=

218)

Unknown
(n

=

344)

p value

Sex (male) (n = 562)

65.2

59 2

0.137

whom we were able to ascertain the presence or

Age at presentation (n = 560)

63.7 yrs

64.1 yrs

0.820

absence of a family history. These patients are

Initial aortic size (n =562)

Mean (cm) (n = 441)

5.01 cm

5.07 cm

0.644

< 3.5 cm

233

27.8

0380

3 3 to 3.9 cm

6.9

10.8

0.104

4.0 to 4.9 cm

35.6

27.8

0.037t

5.0 to 5.9 cm

19.3

18.1

0.711

6.0 to 6.9 cm

6.0

9.2

0.160

a 7.0 cm

8.6

6.8

0.406

Ascending/Arch (n =275)

112

71.8

0.242

Descending/thoracoabdominal
(n = 97)

22.8

28.2

0.242

compared to the 344 patients in whom we were
not able to obtain a family history. Overall, the
two populations are similar in terms of aneunsmal

Aneurysm Location

disease. However, patients we contacted were
more likely to have a type B dissection {p -

Dissection (n = 562)

0.003) and an aneurysm in the 4.0 to 4.9 cm range
at presentation (p = 0.037), as well as a history of

Any

45.5

353

0.024t

Type A

23.6

213

0317

Type B

26.6

163

0.0034

Number of Aneurysms (n

pulmonary disease (p = 0.007) or stroke (p
=0.035).

=562)4

None

9.9

12.4

0.0714

Single

61.4

65.1

0.0714

Multiple

28.8

22.4

0.0714

Comorbidities

Two hundred thirty-three patients with¬
out MFS were interviewed. Of the 233 patients,
44 (29 men, 15 women) (18.9%) were found to
have at least 1 first-degree relative with aneurismal disease, and were considered non-MFSrelated familial (nMFS familial); the remaining

Hypertension (n = 493)

612

69.8

0340

Cardiac History (n = 449)

39.8

443

0.351

Carotid History (n = 429)

13.9

14.4

0.894

Renal History (n = 450)

11.4

13.1

0378

Tobacco Use (n = 445)

42.4

39.9

0399

Pulmonary Disease (n = 465)

26.8

16.3

0.006t

CAD ( n = 603)

253

26.0

0.864

CVA (n = 603)

5.6

103

0.0354

AAA (n = 603)

123

123

0.918

CHF (n = 603)

82

11.1

0.242

t Statistically significant difference between groups (T-test for difference
between means in analysis of variance).
4 p value for Mantel-Haenszel yf for increasing frequency of multiple
aneurysms in patients with known history.

cases were considered sporadic. Table 15 summarizes the demographic and clinical characteristics of these 44 patients with nMFS familial aortic disease
(two patients P557A, P557B, were determined to be in the same family). Patients with nMFS familial aor¬
tic disease had a similar incidence of dissection when compared with sporadic cases (52.3% vs. 43.9%, p =
0.316), and a similar frequency of aortic disease in the ascending aorta (76.7% vs. 77.3%, p = 0.940). In
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contrast, the patients with
MFS had a lower incidence of
dissection (20.0% p = 0.001)
and were much more likely to

Table 15. Demographics and clinical characteristics of patients with non-MFS-related familial thoracic
aortic disease .*
Pedigree
P026
P030
P041
P042
P090
P091
P098

have disease in the ascending
aorta (97.1%,/? = 0.029).
There was a statisti¬
cal trend toward younger
presentation in patients with
nMFS familial aortic disease
than in sporadic cases (58.7
years vs. 65.0 years), and both
groups were significantly
older than patients with MFS
(26.0 years,/? = 0.0001). Pa¬
tients with MFS had a
significantly lower prevalence
of nearly all comorbidities as
shown in Table 16 and de¬
picted graphically in Figure
36.

Age, Tobacco
y/ Sex
Use
58/M
38/M
76/F
58/M
61/F

P107
Pill
P141

35/M
35/M
80/F
49/M
52/M

P145
PI 67
PI 84

24/M
58/F
73/F

P188
P190
P211
P256
P265
P271
P286
P324

58/M
36/M
47/M
65/M
75/M

P330
P335
P345
P366
P422
P422
P470

none
none
none
severe
mild
none
none

HTN
none
none

mild
none
none
mild
none

none
none

none
none

mild
moderate
moderate
none
none

moderate mild
mild
mild
severe

moderate
none
none

moderate
none
severe

none
severe
severe
none
none

none
moderate
mild
none
none
severe

none
none

none
none
none

none

none

mild
none
mild

moderate
none
moderate

none

none
severe

none
severe
none
mild
none

Pulmonary Cardiac
Disease
Disease

mild
mild
none

moderate
none

Initial Aortic
Size (cm)
5.4
45
3.9
75
3.5
4.0
12

3.8
75
5.0

severe
severe

79/F
15/F
82/F

none
moderate
none
none
moderate severe

none
none
none

moderate
moderate

4.0
4.0
6.0
45
5.9

moderate

none

moderate

4.0

48M

4.0

38/M

none
none

P511
P518
P546
P547

65/M
76/F
69/M

none
none
none

none
moderate
mild

75/M

mild

mild

P557A

IP

P557B
P563
P565
P571
P572

59/M
72/F
64/M
7M
60/M

P591
P604
P666

81/F
47/F
60/F

P703
P906
P933

68/M
86/M
64/M

JU

mild
severe

none
mild

none

none
none
mild
none

none
none
moderate

42

mild

42

mild
moderate
mild

none
mild
none

severe
none

mild
none
moderate
none

none

none

mild

mild
none
none

none
mild
mild

moderate
moderate
none

none
mild
moderate

mild

none

none
mild

severe

none

—
—
—
—

-

—

Type A

Asc
Asc

Type A

—

Asc
Asc
TA
TA
Asc
Arch
Arch
Arch
Asc

—

Type A
—
—
—

Type A
Type B
—
—
—

Asc
Asc
Asc
Asc
Asc

42

Asc

55

Asc
Desc
Asc
Asc

4.1
none
none
none

Dissection

—

4.6
4.8
9.8
6.0
4.1
4.0

74/M
64/F

57/F
66/M

Site
Asc
Asc
Asc
Desc
Desc

—
—

Type B
Type B
—

Type A
Type B
Type A
—

Type B
—
—

—

Type A

5.0
6.0

Asc
TA

Type B

73

Desc

—

—
—

—

4.1
53
45
62
5.0

Asc
Asc
Asc
Asc
TA

Type B
—

Type A
—
—

-

* . indicates that the information was not available for a specific patient (this occurred when presentation
occurred to an outside hospital and data related to the patient's presentation could not be reliably retrieved
in a format consistent with that retrieved for patients seen at Yale-New Haven, — indicates that the patient
did not have a particular type of aortic disease.

In particular, the rates of hypertension and vascular diseases were markedly lower in patients with

MFS than in the other two groups: no patients with MFS had renal or carotid disease, and only 15.1% had a
history of hypertension (versus 60.8% of nMFS familial and 68% of sporadic,/? = 0.001). Patients with
nMFS familial aneurysms did not differ significantly from those with sporadic aortic disease, although
there was a slight trend toward a reduced incidence of hypertension. Data is not shown for the analysis of
comorbidities based on the stratified severity scores because no difference was statistically significant.
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Table 16. Comparison of patients with sporadic, nMFS familial, and MFS-related thoracic aortic disease *
Sporadic

Variable

189 (123 M.66F)

No. of patients (sex)

65.0 (62.7 to 67.4)f

Age (yrs)

5.1 (4.6 to 5.6)

Initial aortic diameter (cm)

nMFS familial

MFS related
60 (40 M, 20 F)

44 (29 M, 15 F)
59.7 (54.8 to 64.7)t

26.0 (21.8 to 30.3)t
4.8(4 3 to 5.2)

5.1 (4.8 to 5.3)

Comorbidities

108 (68.8%)^

23 (60.5%)t

8 (15.1%)$

Cardiac Disease

53 (38.4%)f

15 (45.5%)t

5 (10.6%)t

Carotid Disease

16 (12.5%)§

6 (20.0%)§

0(0.0%)§

Renal Disease

17 (12.2%)§

3 (8.1 %)§

Pulmonary Disease

58 (43.0%)

15 (40.5%)

Tobacco Use

35 (24,1%)5

14 (36.8%)3

CAD

47 (24.9%)5

12 (27.7%)S

AAA

22 (11.6%)

7 (15.9%)

CVA

10 (5.3%)

CHF

12 (6.4%)§

Hypertension

0 (0.0%)§
11 (23.4%)
3 (6.4%)3
3 (5.0%)5
6 (10.0%)

3 (6.8%)

1 (1.7%)

7 (15 9%)§

3 (5.0%)§

0.08

0.13

0.13

(-0.02 to 0.18)

(0.04 to 0.22)

(0.06 to 0.21)

Growth rate (cm/yr)

* Values are given as N (%), or as mean with 95% confidence intervals in parentheses where appropriate. The Bonferonni test for differ¬
ences between means was used in the analysis of variance procedure, x2 test was used 10 evaluate difference in prevalence of comorbidities
between groups. Percentages and N values may not correspond across rows because some patients were excluded from each analysis be¬
cause of incomplete information.

ip <0.0001
%p< 0.001
§ p < 0.05
5 p < 0.005

100%

Hypertension Cardiac

Carotid

Renal

Disease

Disease

Disease

Pulmonar^obacco Use

CAD

AAA

CVA

CHF

Disease

Figure 36. Prevalence of comorbidities analyzed by the presence of a family history.
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Pedigree Analysis
Figure 37 displays the family
^■^□□□OOOO

pedigrees of a representative group of 26
out of the 44 patients and their first-order

ro27

^
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are consistent with autosomal recessive;
however, the high frequency of affected
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_DO_
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□*_

P557

□■OQDCd

P563

sents incomplete penetrance of the

P565

fno

90

ooioD

• DODD
t

disease phenotype, rather than a distinct

P580

■□!

mode of inheritance. Some pedigrees
*lfe>

may also be consistent with X-linked
inheritance (for example, P141, P167,

DO
O0B0
OMBQ
t

Figure 37. Pedigrees for 26 families with nMFS familial aortic disease. Squares repre¬
sent men and circles women. An arrow indicates the proband with thoracic aortic
disease. Blackened squares or circles represent affected patients with aortic aneurysms.

P184).

Aneurysm Growth Rates
The initial aortic diameter at the time of diagnosis
Table 17. Comparison of aortic growth rate according to

was the same for patients with sporadic disease and those

dissection status in patients with sporadic, nMFS familial,
and MFS-related thoracic aortic aneurysms.*
Aortic Dissection

with nMFS familial aortic disease (Table 16). Patients with
MFS tended to have smaller aortic diameter at presentation.
Aortic aneurysm growth rates for the sporadic, nMFS famil¬
ial, and MFS-related TAA are displayed in Table 15 and
Table 17. Although sample sizes were not sufficient to dem-

Sporadic

nMFS familial

MFS related

Overallt

No Dissection

0.09

0.06

(-0.06 to 026)

(-0.04 to 0.17)

0.16

0.13

(-0.01 to 034)

(0.03 to 0.24)

0.18

0.13

(0.05 to 0.32)

(0.04 to 0.21)

0.13

0.08

(0.05 to 0.20)

(0.06 to 0.11)

* Values indicate aortic growth rate based on regression
analysis for patients with and without aortic dissection.
95% confidence intervals for the mean are given in paren¬
theses
t Includes patients in whom the family history status is not
known.
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onstrate statistical significance, patients with nMFS

100% ta__

-^

familial disease, and those with MFS had higher
growth rates for both dissected and non-dissected an¬
eurysms. Growth rates for dissected aneurysms were
0.16 cm per year in nMFS familial patients, and 0.18

nMFS familial
— sporadic
-

40%

20%

0% J-t-r-r-.-

cm per year in patients with MFS. Sporadic patients

0

1

2

3

4

5

Years

with dissection had growth rates of only 0.06 cm per
Figure 38. Kaplan-Meier cumulative survival prior to operative repair.
Five-year survival estimates are illustrated for patients as a function of

year.

familial history. (p = 0.997)

Long-Term Survival
The survival prior to operative repair was not
significantly different between patients with a family
history and those without (p = 0.997, Figure 38). Pre¬
dictors of preoperative death were similar in this
population to the entire population, and the presence
Years

or absence of a family history did not enter into a pro¬

Figure 39. Kaplan-Meier cumulative survival. Five-year survival

portional hazards model which continued to

estimates are illustrated for patients as a function of familial history, ip
= 0.0902)

Table 18. Proportional hazards regression of factors predicting decreased long-term survival when familial history is included as a risk factor (dependent
variables).§
Regression Analysis

Conservative Model

Entry at

p<0.05*

Variable

Parameter estimate

Standard error

p Value

Size

1.2045031

0.46678

0.0099f

3.335f

(1.336-8.326)

Cardiac Disease*’

1.125778ft

0.46606

0.0157ft

3.083ft

(1.237 - 7.685)

Regression Analysis

Liberal Model

Entry at

p < 0.70"

Variable

Parameter estimate

Standard error

p Value

2

6.0 cm1

Risk Ratiof

Risk Ratio f

Initial Aortic Size
3.5 - 3.9 cm

-14.54718

1715

0.4559

0.000

N/A

ar 6.0 cm

0,909644

0.47785

0.0570

2.843

(0 973 - 6.336)

nMFS familial history

0.466472

0.71212

0.5124

1.594

(0.395

6.438)

Age at presentation (per year)

0.023342

0.01736

0.1789

1.024

(0.989

1.059)

Location (Desc/TA)

0.566817

0.69088

0.4120

1.763

(0.455 -6.827)

Pulmonary Disease

-0.675778

0.60925

0.2673

0.509

(0.154 - 1.679)

AAA

0.820452

0.70731

0.2461

2.483

(0.973 - 6.336)

Cardiac Disease11

1.129986ft

0.57202

0.0482ft

3.096tf

(1.009

9.498)

§ This variable equals 1 if the patient incurred died and 0 otherwise.
♦Criteria for assessing model fit: -2 Log L: without covariates: 138.583; with covariates: 125.499; y1 for covariates: 13.084 with 2 DF Ip = 0.0014)
** Criteria for assessing model fit: -2 Log L: without covariates: 138.583; with covariates: 118.030;

for covariates: 20.552 with 8 DF ip =0.0084)

t 95% confidence intervals on odds ratios are given in parentheses,
t Statistically significant at the 1% level,
ft Statistically significant at the 5% level.
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demonstrate similar predictors of decreased survival as noted above (Table 13).
Long-term survival between groups (independent of operative repair) did not differ significantly in
a life-table analysis (p = 0.0902XFigure 38), and the conservative proportional hazards model demonstrated
only that size

2

6.0 cm and a history of cardiac disease predicted poor long-term survival (Table 18). How¬

ever, under the less conservative multivariable model (Table 18) there was a trend toward an increased risk
of death over time in patients with nMFS familial disease (odds ratio 1.594, 95% Cl 00.395 - 6.438).
Other predictors of earlier mortality in this population included location of the aneurysm in the descending
or thoraco-abdominal aorta, increasing age at presentation, and a history of cardiac disease.
However, a serious limitation of long¬
term survival analysis in this population becomes
evident when the survival function of patients
included in the analysis is compared to survival in
those in whom we were unable to ascertain a
family history.

Mortality in the group we were

able to contact (independent of family history

Figure 40. Kaplan-Meier cumulative survival. Five-year survival esti¬
mates are illustrated for patients as a function of whether or not we were

status) was significantly lower than in the group

able to ascertain a family history, {p = 0.0003)

with unknown family history (p = 0.0003) (Figure 40).
Analysis of linkage was performed on a single family with nMFS familial aortic disease in order
to assess the potential for linkage in this family to the genetic locus containing the FBN1 gene. Affected
individuals in this family did not share any alleles at the FBN1 locus, excluding defects in fibrillin as a
potential cause in this family.
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Aneurysm Growth Rates
Growth rates in this population were consistent with previous estimates.4,60'64 The mean aortic
growth rate was 0.10 cm per year. Sample sizes in the groups analyzed were not sufficient to assess statis¬
tical significance; however, some trends can be noted. The largest aneurysms (a 6.0 cm) grew at higher
rates than smaller aneurysms. Surprisingly, the smallest aneurysms (< 4.0 cm) grew at particularly high
rates, even when the incidence of concomitant dissection and Marfan disease were accounted for. This
high rate may reflect the inclusion of aneurysms in the aortic root where the sinuses can dilate rapidly and
asymmetrically. Because we used maximal aortic diameter, rather than cross-sectional area as our meas¬
urement of aortic size, the size and growth rates of these aneurysms may have been over-estimated.
Consistent with previous reports,4,60,64 aneurysms in the descending or thoraco-abdominal aorta, those with
concomitant dissection and those in patients with a history of pulmonary disease or with Marfan syndrome
also tended to grow faster.

Analysis of Complications
Examining the natural history of thoracic aortic aneurysms is complicated by a number of issues
specific to the disease which make scientific assessments of risks difficult. Patients with large aneurysms,
high rates of growth between imaging studies, and those with significant symptoms are usually selected for
surgical intervention. Those who were not selected for surgery may have been excluded as operative candi¬
dates because of significant comorbidities. Therefore, studies of risk factors for complications require large
sample sizes. This is the first report from our center in which data is robust enough (1383 years of patient
follow-up before surgical intervention) to permit statistically valid calculation of yearly rates of rupture or
other complications for aneurysms of different sizes.
This study confirms that thoracic aortic aneurysm is intrinsically a lethal disease and that aneu¬
rysm size has a profound impact on rupture, dissection and death. In the conservative proportional hazards
models, size is the only predictor of increased risk of rupture and one of two factors predicting increased
risk for the compound end-points of rupture or dissection and rupture, dissection or death.
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We find that the mean rate of rupture or dissection is only 2% per year for small aneurysms, rises
to 3% for aneurysms 5.0 to 5.9 cm, and jumps to 6.9% for aneurysms greater than 6.0 cm in diameter. The
risk of rupture alone is near zero for small aneurysms, rises to 1.7% per year for aneurysms 5.0 to 5.9 cm,
and jumps to 3.6% per year for aneurysms greater than 6.0 cm in diameter.

Using a multivariable propor¬

tional hazards model, we estimate a 15-fold increase in risk with aortic size £ 6.0 cm versus that for
aneurysms 4.0 to 4.9 cm. The risk of rupture, dissection or death from all causes is 6.5% at aneurysm size
5.0 to 5.9 cm and jumps to 14.1% per year for aneurysms greater than 6.0 cm. These data confirm the
devastating prognosis associated with aneurysms s 6.0 cm which we identified in our previous work.66
It is anticipated that these size-specific rates may be of use in counseling individual patients pre¬
senting for consideration of elective pre-emptive surgical extirpation of asymptomatic aneurysms. These
data confirm that thoracic aortic aneurysm is a highly lethal condition and support pre-emptive surgical
correction. It is important to emphasize that this data is for asymptomatic aneurysms and that symptomatic
aneurysms require extirpation regardless of size. The general thrust of this data suggests intervention be¬
fore aneurysm size reaches 6.0 cm, consonant with findings and recommendations from our earlier report
on a smaller number of patients.66
For individual patients at specific centers, the center’s surgical risk can be factored into
the decision-making. At our institution, for experienced operators, hospital mortality is 2.5% for elective
ascending and arch and 10.9% for elective descending and thoraco-abdominal aortic operations.117 This
indicates that surgical repair done electively promises lifetime protection at a mortality “cost” comparable
to, or less than, a single year’s natural rupture or dissection rates. The very flat survival curve (Figure 35)
following pre-emptive surgical repair approaches that of a normal age and sex matched population and con¬
firms vividly that surgical repair protects life long-term.
Certain limitations of these data can be enumerated. Definition of rupture, dissection,
and aneurysm-related death was strict, as we required in-hospital documentation by imaging studies, surgi¬
cal findings, or post-mortem examination. The mortality calculations are immune from this factor and
represent true rates. Second, patients we followed were operated on electively when they reached size cri¬
teria, thus eliminating them from susceptibility to rupture or dissection. The only patients with very large
aneurysms followed without surgery were those cared for elsewhere before referral to us, those refusing
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surgery, or those felt to be non-operative candidates. These two factors —strict definition of aneurysmrelated events, and limitation of patients at risk by pre-emptive surgery—imply that the yearly rates we
have presented represent minimum lower limits of the actual rates. Some out of hospital deaths were cer¬
tainly aneurysm-related. Thus, in decision-making and counseling, we can presume that the risk of rupture
or dissection is at least 6.4% per year for 6 cm aneurysms. On the other hand, the rupture rate cannot ex¬
ceed the combined endpoint rate of 14.1%, as unidentified/unrepaired rupture is a lethal event.
Two interesting and not anticipated findings of our study are that comorbid vascular disease in¬
creased the risk of rupture (odds ratio > 2-fold) and that male sex provides some relative protection (odds
ratio 0.365). The former implicates complex processes of vascular biology in the growth of aneurysms and
their subsequent rupture. The latter suggests that women require closer scrutiny, possibly because a spe¬
cific size aneurysm represents proportionately greater aortic dilatation in smaller patients of female sex.
That is, female sex may be a surrogate for low body surface area in this report.
Another issue has to do with the influence of concomitant pulmonary disease on aortic events.
Multiple prior studies have shown such correlation ,5i-60-65 We found an adverse impact of pulmonary disease
on the rate of growth of the aorta, but did not confirm an impact on rupture or dissection. Regarding hy¬
pertension, like Griepp’s group,65 we did not uncover a direct increase in rupture or dissection. As
previously described65 it is likely that this indicates adequate treatment of hypertension, rather than a lack
of effect of high blood pressure on aortic growth and rupture. A prospective study with serial blood pres¬
sure measurements would be required to fully assess the impact of high blood pressure (as opposed to
merely a history of hypertension) in this population.
As would be expected, we found increasing size is more strongly associated with an increased risk
of rupture, rather than an increased risk of dissection. Dissection may occur at smaller sizes due to other
factors (such as connective tissue disease from Marfan syndrome or bicuspid aortic valve), whereas rupture
appears to be a predominantly size-related event.

The Impact of Genetic Risk Factors
The initial results from our analysis of familial patterns of TAA were published in 1999.3 Since
that time we have identified an additional 18 patients with nMFS familial aortic disease. Consistent with
our previous publication and that of Biddinger et al.107 in 1997, we report a familial aggregation of thoracic
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aortic disease in 19% of patients. Ascertainment bias likely explains the trend toward younger presentation
in patients with nMFS familial disease and those with MFS. That is, patients with a close relative with an
aneurysm may seek medical attention earlier than patients with sporadic TAA, and patients with MFS are
screened for asymptomatic disease.
Hypertension is significantly associated with thoracic aortic disease in both familial and sporadic
patients (68.8% and 60.5%), but not in patients with MFS. Although it is well known that hypertension is
associated with aortic aneurysms, aneurysm formation cannot be ascribed to elevated blood pressure
alone.107 The low rate of hypertension in patients with MFS suggests that inherent vessel weakness due to
the genetic defect in the fibrillin gene may represent the greatest influence on aneurysm formation in these
patients. Differing levels of genetic susceptibility to aneurysm formation may be reflected in the trend to¬
ward increased aortic growth rates seen in patients with familial disease despite similar levels of
hypertension.
It was surprising to find the incidence of comorbidities to be similar in the nMFS familial and the
sporadic cases. This may reflect the heterogeneous nature of the population described as nMFS familial.
Some of these patients may have severe genetic defects similar to those in MFS, while others may have
very mild genetic defects. This is consistent with the pattern seen with defects in fibrillin, since a number
of reports have described patients with well-characterized genetic defects in fibrillin who do not manifest
the full-spectrum of MFS.108,122
Pedigree analysis suggests a dominant mode of inheritance with reduced penetrance. This is con¬
sistent with a complex disease in which disease genotype is associated with an increased susceptibility to
as-yet-undefined environmental effects (for example, hypertension or chronic infection or inflammatory
processes). Linkage analysis in a single family with familial nMFS disease has excluded FBN1 as a poten¬
tial candidate gene indicating that other genes are involved in the predisposition toward aortic aneurysm
formation.
Several limitations of this study should be mentioned. Long-term survival in the patients in whom
we were able to ascertain a family history is significantly better than those who we were not able to contact.
This suggests that we have interrogated a population with less severe disease on average. The prospective
identification of patients following our initial publication should mitigate this effect as we continue to
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gather patients. Because this study includes only families with previously diagnosed disease, it is likely
that we failed to include some families with undiagnosed asymptomatic TAA and AAA. Likewise a rela¬
tive may have died before aneurysms became symptomatic. Because we proceeded conservatively and did
not include patients with a history of sudden death in the family, our estimate of 19% prevalence of familial
aggregation should be taken as a lower limit of the true prevalence.
In order to minimize non-inclusion of asymptomatic disease, we hope to screen all first-degree
family members of our pedigrees to identify additional patients with undetected aneurysm and to confirm
or refute absence of aortic disease in other family members.

Summary
This report confirms that 19% of families demonstrate familial aggregation of thoracic aortic dis¬
ease. While sample sizes were too small to assess statistical significance in this population, it appears that
patients with non-Marfan-related familial thoracic aortic disease have similar clinical and demographic
characteristics as sporadic cases. In addition, they may have higher growth rates and a worse long-term
survival. Larger, prospective studies need to be performed in order to assess the true risk associated with a
family history of thoracic aortic disease. Whole genome analysis of linkage using families with a signifi¬
cant number of living, affected individuals will likely be required in order to establish the nature of genetic
risk in this population.
Our review of the natural history of thoracic aortic aneurysms prior to surgical repair permits the
following conclusions. Thoracic aortic aneurysm is a lethal disease. Forty-six percent of patients with
large aneurysms will die within 5 years. Aneurysm size has a profound impact on rupture, dissection, and
death. For counseling purposes, the patient with an aneurysm exceeding 6 cm in diameter can expect a
yearly rate of rupture or dissection of at least 6.4% and a death rate of 10.8% per year. Elective surgery
eliminates the risk of rupture and restores survival to near normal. Elective surgical repair can be accom¬
plished at a “cost” of less than a single year’s expected natural mortality. Careful follow-up of patients
with thoracic aortic aneurysms is essential, with pre-emptive extirpation before the dangerous diameter
criterion of 6 cm. It is hoped that these data will permit concrete estimation of the natural history side of
the balance of relative risks and benefits of medical management versus surgical intervention for specific
patients.

51

Davies et al. — The Natural History of Thoraac Aortic Disease

References

REFERENCES
1.
2.
3.
4.
5.

6.

7.
8.
9.
10.
11.

12.
13.
14.
15.
16.
17.
18.

19.
20.

21.
22.

23.

Davies RR, Goldstein LJ, Coady MA, et al. Yearly rupture/dissection rates for thoracic aortic
aneurysms: simple prediction based on size. Ann Thorac Surg 2000; [in press].
Coady MA, Davies RR, Hammond GL, Kopf GS, Elefteriades JA. Familial inheritance of
thoracic aortic aneurysms [abstract]. Circulation 1999; 98 Suppl S.
Coady MA, Davies RR, Hammond GL, Rizzo JA, Elefteriades JA. Familial patterns of tho¬
racic aortic aneurysms [abstract]. Transactions of the New England Surgical Society 1998; 79.
Coady MA, Davies RR, Roberts M, et al. Familial patterns of thoracic aortic aneurysms. Arch
Surg 1999; 134:361-7.
Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. Cell junctions, cell adhesion, and
the extracellular matrix. Molecular Biology of the Cell. New York NY: Garland Publishing,
1994:949-1009.
Dobrin PB. Vascular mechanics. In: Shepherd JT, Abboud FM, eds. The Cardiovascular
System Handbook of Physiology. Vol. 3. Washington, D.C.: American Physiological Society,
1983:65-102.
Dobrin PB. Mechanics of normal and diseased blood vessels. Ann Vase Surg 1988; 2:283294.
Barnes MJ. Collagens of normal and diseased blood vessel wall. In: Nimni ME, ed. Collagen
I Biochemistry. Boca Raton, FL: CRC Press, 1988:271-291.
Kivirikko KI. Collagens and their abnormalities in a wide spectrum of diseases. Ann Med
1993;25:113-26.
Pereira L, Andrikopoulos K, Tian J, et al. Targetting of the gene encoding fibrillin-1 reca¬
pitulates the vascular aspect of Marfan syndrome. Nat Genet 1997; 17:218-22.
Mecham RP, Davies E. Elastic fiber structure and assembly. In: Yurchenco PD, Birk DE,
Mecham RP, eds. Extracellular Matrix Assembly and Structure. New York, NY: Academic
Press, 1994:281-314.
Dietz HC, Cutting GR, Pyeritz RE, et al. Marfan syndrome caused by a recurrent de novo
missense mutation in the fibrillin gene. Nature 1991; 352:337-9.
Wolinsky H, Glagov S. A lamellar unit of aortic medial structure and function in mammals.
CircRes 1967; 20:99-111.
Wolinsky H, Glagov S. Comparison of abdominal and thoracic aortic medial structure in
mammals. Deviation of man from the usual pattern. Circ Res 1969; 25:677-86.
Wolinsky H. Comparison of medial growth of human thoracic and abdominal aortas. Circ Res
1970;27:531-8.
Coady MA, Rizzo JA, Goldstein LJ, Elefteriades JA. Natural history, pathogenesis, and etiol¬
ogy of thoracic aortic aneurysms and dissections. Cardiol Clin 1999; 17:615-35; vii.
Dobrin PB. Mechanical properties of arteries. Physiol Rev 1978; 58:397-460.
Patel DJ, Greenfield JC, Fry PL. The in vivo pressure-length radius relationship to certain
blood vessels in man and dog. In: Attinger O, ed. Pulsatile Blood Flow. New York, NY:
McGraw-Hill, 1964.
Patel DJ, Janicki JS, Carew TE. Static anisotropic elastic properties of the aorta in living dogs.
Circ Res 1969; 25:765-79.
Borst HG, Heinemann MK, Stone CD. Pathogenesis. In: Borst HG, Heinemann MK, Stone
CD, eds. Surgical Treatment of Aortic Dissection. New York, NY: Churchill Livingstone,
1996:47-54.
Garfield RE, Chacko S, Blose S. Phagocytosis by muscle cells. Lab Invest 1975; 33:418-27.
White JV, Scovell SD. Etiology of abdominal aortic aneurysms: the structural basis for aneu¬
rysm formation. In: Calligaro KD, Dougherty MJ, Hollier LH, eds. Diagnosis and Treatment
of Aortic and Peripheral Arterial Aneurysms. Philadelphia, PA: Saunders Co., 1999.
White JV. Role of adventitial defects in the pathogenesis of aortic aneurysms. In: Veith F, ed.
Current Critical Problems in Vascular Surgery. Vol. 5. St. Louis, MO: Quality Medical Pub¬
lishing, 1993:293-301.

52

Davies et al. — The Natural History of Thoracic Aortic Disease

24.
25.
26.
27.
28.
29.
30.

31.
32.
33.
34.
35.
36.

37.
38.
39.
40.
41.
42.
43.
44.
45.
46.

47.
48.
49.

References

Burton AC. Relation of structure to function of tissues of wall of blood vessels. Physiol Rev
1954; 34:619.
Wolinsky H, Glagov S. Structural basis for the static mechanical properties of the aortic me¬
dia. Circ Res 1964; 14:400.
White JV, Mazzacco SL. Formation and growth of aortic aneurysms induced by adventitial
elastolysis. Ann N Y Acad Sci 1996; 800:97-120.
Crawford ES, DeNatale RW. Thoracoabdominal aortic aneurysm - natural history and treat¬
ment. J Thorac Cardiovasc Surg 1986; 79:489-98.
Pitt MP, Bonser RS. The natural history of thoracic aortic aneurysm disease: an overview. J
Card Surg 1997; 12:270-8.
Bickerstaff LK, Pairolero PC, Hollier LH, et al. Thoracic aortic aneurysms: a populationbased study. Surgery 1982; 92:1103-8.
Ergin MA, Griepp RB. Dissections of the Aorta. In: Baue AE, Geha AS, Hammond GL, Laks
H, Naunhelm KS, eds. Glenn's Thoracic and Cardiovascular Surgery. Norwalk, CT:
Appleton & Lange, 1996:2273-2298.
Cooke JP, Kazmier FJ, Orszulak TA. The penetrating aortic ulcer: pathologic manifestations,
diagnosis, and management. Mayo Clin Proc 1988; 63:718-25.
Stanson AW, Kazmier FJ, Hollier LH, et al. Penetrating atherosclerotic ulcers of the thoracic
aorta: natural history and clinicopathologic correlations. Ann Vase Surg 1986; 1:15-23.
Welch TJ, Stanson AW, Sheedy PFd, Johnson CM, McKusick MA. Radiologic evaluation of
penetrating aortic atherosclerotic ulcer. Radiographics 1990; 10:675-85.
Coady MA, Rizzo JA, Elefteriades JA. Pathologic variants of thoracic aortic dissections.
Penetrating atherosclerotic ulcers and intramural hematomas. Cardiol Clin 1999; 17:637-57.
Roberts WC. Aortic dissection: anatomy, consequences, and causes. Am Heart 7 1981;
101:195-214.
Coady MA, Rizzo JA, Hammond GL, Pierce JG, Kopf GS, Elefteriades JA. Penetrating ulcer
of the thoracic aorta: what is it? How do we recognize it? How do we manage it? 7 Vase Surg
1998; 27:1006-15; discussion 1015-6.
Hirst AEJ, Johns VJ, Kime SWJ. Dissecting aneurysm of the aorta: A review of 505 cases.
Medicine 1958; 37:217-271.
Sterpetti AV, Hunter WJ, Feldhaus RJ, al. e. Inflammatory aneurysms of the abdominal aorta:
incidence, pathologic, and etiologic considerations. 7 Vase Surg 1989; 9:643-650.
Goldstone J, Malone JM, Moore WS. Inflammatory aneurysm of the abdominal aorta. Sur¬
gery 1983; 83:425-430.
Sethia B, Darke SG. Abdominal aortic aneurysm with retroperitoneal fibrosis and ureteric en¬
trapment. Br J Surg\ 70:434-436.
Movat HZ, More RH, Haust MD. The diffuse internal thickening of the human aorta with
aging. Am J Pathol 1958; 34:1023-1031.
Schlatmann TJM, Becker AE. Histologic changes in the normal aging aorta: implications for
dissecting aortic aneurysm. Am J Cardiol 1977; 39:13-20.
Doll R, Peto R. Mortality in relation to smoking: 20 years observations in male British doc¬
tors. BMJ 1976; ii: 1525-36.
Hammond EC, Garfinkel L. Coronary artery disease, stroke, and aortic aneurysm. Factors in
etiology. Arch Environ Health 1969; 19:167-182.
Kahn H. The Dom study of smoking and mortality among US veterans: report on 8.5 years of
observation. National Cancer Institute Monographs 1966; 19:1-125.
George PM, Travis J, Vissers MCM, Winterboum CC, Carrell RW. A genetically engineered
mutant of alpha-1-antitrypsin protects connective tissue from neutrophil damage and may be
useful in lung disease. Lancet 1984; ii: 1426-1428.
Carrell RW. Alpha-1-antitrypsin: molecular pathology, leucocytes, and tissue damage. 7 Clin
Invest 1986; 78:1427-1431.
Gardner RJ, Lancaster JR, Tamay TJ, Warden HE, Currie RA. Five year history of surgically
treated abdominal aortic aneurysms. Surg Gynecol Obstet 1970; 130:981-7.
Gwathmey O, Adkins PC, Blades B. Emergency and elective treatment of abdominal aortic
aneurysms. Postgrad Med J 1959; 25:677-684.

53

Davies et al. - The Natural History of Thoracic Aortic Disease

50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.

71.
72.
73.
74.
75.
76.

References

Gore I, Hirst AE, Jr. Arteriosclerotic aneurysms of the abdominal aorta: a review. Progress in
Cardiovascular Diseases 1973; 16:113-50.
Cronenwett JL, Murphy TF, Zelencock GB, al. e. Actuarial analysis of variables associated
with rupture of small aortic aneurysms. Surgery 1985; 98:472-483.
Cronenwett JL, Sargent SK, Wall MH, et al. Variables that affect the expansion rate and out¬
come of small abdominal aortic aneurysms. J Vase Surg 1990; 11:260-8; discussion 268-9.
MacSweeney ST, Powell JT, Greenhalgh RM. Pathogenesis of abdominal aortic aneurysm. Br
JSurg 1994;81:935-41.
Osier W. Aneurysm of the abdominal aorta. Lancet 1905; 2:1089-1096.
Maniglia R, Gregory JE. Increasing incidence of arteriosclerotic aortic aneurysms. Analysis
of six thousand autopsies. Arch Pathol 1952; 54:298-305.
Svensjo S, Bengtsson H, Bergqvist D. Thoracic and thoracoabdominal aortic aneurysm and
dissection: an investigation based on autopsy. Br J Surg 1996; 83:68-71.
Pressler V, McNamara JJ. Thoracic aortic aneurysm: natural history and treatment. J Thorac
Cardiovasc Surg 1980; 79:489-98.
DeBakey ME, Noon GP. Aneurysms of the thoracic aorta. Mod Concepts Cardiovasc Dis
1975; 44:53-8.
Joyce JW, Fairbaim J, Kincaid OW, al. e. Aneurysms of the thoracic aorta - A clinical study
with special reference to prognosis. Circulation 1964; 29:176-181.
Cambria RA, Gloviczki P, Stanson AW, et al. Outcome and expansion rate of 57 thoracoab¬
dominal aortic aneurysms managed nonoperatively. Am J Surg 1995; 170:213-7.
Dapunt OE, Galla JD, Sadeghi AM, et al. The natural history of thoracic aortic aneurysms. J
Thorac Cardiovasc Surg 1994; 107:1323-32; discussion 1332-3.
Rizzo JA, Darr U, Fischer M, et al. Multi-modality serial follow-up of thoracic aortic aneu¬
rysms. Int J Angiol 1997; 6:153-156.
Hirose Y, Hamada S, Takamiya M, Imakita S, Naito H, Nishimura T. Aortic aneurysms:
growth rates measured with CT. Radiology 1992; 185:249-52.
Masuda Y, Takanashi K, Takasu J, Morooka N, Inagaki Y. Expansion rate of thoracic aortic
aneurysms and influencing factors. Chest 1992; 102:461-6.
Juvonen T, Ergin MA, Galla JD, et al. Prospective study of the natural history of thoracic
aortic aneurysms. Ann Thorac Surg 1997; 63:1533-45.
Coady MA, Rizzo JA, Hammond GL, et al. What is the appropriate size criterion for resection
of thoracic aortic aneurysms? J Thorac Cardiovasc Surg 1997; 113:476-91.
Darling RC. Ruptured arteriosclerotic abdominal aortic aneurysms. A pathologic and clinical
study. Am J Surg 1970; 119:397-401.
Cronenwett JL. Variables that affect the expansion rate and rupture of abdominal aortic aneu¬
rysms. Ann N Y Acad Sci 1996; 800:56-67.
Szilagyi DE, Elliott JP, Smith RF. Clinical fate of the patient with asymptomatic abdominal
aortic aneury sm and unfit for surgical treatment. Arch Surg 1972; 104:600-6.
Foster JH, Bolasny BL, Gobbel WG, Jr., Scott HW, Jr. Comparative study of elective resec¬
tion and expectant treatment of abdomianl aortic aneurysm. Surg Gynecol Obstet 1969; 129:19.
Sterpetti AV, Cavallaro A, Cavallari N, et al. Factors influencing the rupture of abdominal
aortic aneurysms. Surg Gynecol Obstet 1991; 173:175-8.
Strachan DP. Predictors of death from aortic aneurysm among middle-aged men: the White¬
hall study. BrJ Surg 1991; 78:401-4.
Boyd LJ. A study of four thousand reported cases of aneurysm of the thoracic aorta. Am J
Med Sci 1924; 168:654-668.
Johansson G, Markstrom U, Swedenborg J. Ruptured thoracic aortic aneurysms: a study of
incidence and mortality rates. J Vase Surg 1995; 21:985-8.
Kampmeier RH. Saccular aneurysm of the thoracic aorta: a clinical study of 633 cases. Ann
Intern Med 1938; 12:624-651.
Masuda Y, Takanashi K, Takasu J, et al. Unoperated thoracic aortic aneurysms: survival rates
of the patients and determinants of prognosis. Intern Med 1992; 31:1088-93.

54

Davies et al. - The Natural History of Thoracic Aortic Disease

77.

78.
79.
80.
81.
82.

83.
84.
85.
86.
87.

88.

89.
90.
91.
92.
93.
94.
95.
96.

97.
98.
99.
100.
101.

References

Kouchoukos NT. Aneurysms of the ascending aorta. In: Baue AE, Geha AS, Hammond GL,
Laks H, Naunhelm KS, eds. Glenn's Thoracic and Cardiovascular Surgery. Norwalk, CT:
Appleton & Lange, 1996:2225-2237.
Majumder PP, St. Jean PL, Ferrell RE, Webster MW, Steed DL. On the inheritance of ab¬
dominal aortic aneurysm. Am J Hum Genet 1991; 48:164-70.
LaRoy LL, Cormier PJ, Matalon TA, Patel SK, Turner DA, Silver B. Imaging of abdominal
aortic aneurysms. AJR Am J Roentgenol 1989; 152:785-92.
Clouse WD, Hallett JW, Jr., Schaff HV, Gayari MM, Ilstrup DM, Melton LJ, 3rd. Improved
prognosis of thoracic aortic aneurysms: a population-based study. JAMA 1998; 280:1926-9.
Lilienfeld DE, Gunderson PD, Sprafka JM, Vargas C. Epidemiology of aortic aneurysms: I.
Mortality trends in the United States, 1951 to 1981. Arteriosclerosis 1987; 7:637-43.
Svensson LG, Crawford ES. Aortic dissection and aortic aneurysm surgery: clinical observa¬
tions, experimental investigations, and statistical analyses. Part II. Curr Probl Surg 1992;
29:913-1057.
Waller BF, Catellier MJ, Clark MA, Hawley DA, Pless JE. Cardiac pathology in 2007 con¬
secutive forensic autopsies. Clin Cardiol 1992; 15:760-5.
Pressler V, McNamara JJ. Aneurysm of the thoracic aorta. Review of 260 cases. J Thorac
Cardiovasc Surg 1985; 89:50-4.
Crawford ES, DeNatale RW. Thoracoabdominal aortic aneurysm: observations regarding the
natural course of the disease. J Vase Surg 1986; 3:578-82.
Cohn LH, Rizzo RJ, Adams DH, et al. Reduced mortality and morbidity for ascending aortic
aneurysm resection regardless of cause. Ann Thorac Surg 1996; 62:463-8.
Shores J, Berger KR, Murphy EA, Pyeritz RE. Progression of aortic dilatation and the benefit
of long-term beta-adrenergic blockade in Marfan's syndrome [see comments]. N Engl J Med
1994; 330:1335-41.
Groenink M, de Roos A, Mulder BJ, Spaan JA, van der Wall EE. Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following betablocker therapy in the Marfan syndrome. Am J Cardiol 1998; 82:203-8.
Collod-Beroud G, Beroud C, Ades L, et al. Marfan database (third edition): new mutations
and new routines for the software. Nucleic Acids Res 1998; 26:229-33.
De Paepe AD, Devereux RB, Dietz HC, Hennekam RCM, Pyeritz RE. Revised diagnostic
criteria for the Marfan syndrome. Am J Med Genet 1996; 62:417-26.
Tsipouras P, Devereux RB. Marfan syndrome: genetic basis and clinical manifestations.
Semin Dermatol 1993; 12:219-28.
Pyeritz RE, McKusick VA. The Marfan syndrome: diagnosis and management. N Engl J Med
1979; 300:772-7.
Tsipouras P, Silverman DI. The genetic basis of aortic disease. Marfan syndrome and beyond.
Cardiol Clin 1999; 17:683-96.
Aoyama T, Francke U, Gasner C, Furthmayr H. Fibrillin abnormalities and prognosis in Mar¬
fan syndrome and related disorders. Am J Med Genet 1995; 58:169-76.
Davies MJ, Treasure T, Richardson PD. The pathogenesis of spontaneous arterial dissection.
Heart 1996; 75:434-5.
Dietz HC. New insights into the genetic basis of aortic aneurysms. In: Schoen FJ, Gimbrone
MA, eds. Monographs in Pathology: Cardiovascular Pathology, Clinicalpathologic Correla¬
tions and Pathogenetic Mechanisms. Vol. 37. Baltimore: Williams and Wilkins, 1995:144-55.
Herskowitz I. Functional inactivation of genes by dominant negative mutations. Nature 1987;
329:219-22.
Chakravorty B, Gleadhill CA. Familial incidence of cerebral aneurysms. BMJ 1966;
5480:147-8.
Tilson MD, Seashore MR. Fifty families with abdominal aortic aneurysms in two or more
first-order relatives. Am J Surg 1984; 147:551-3.
Norrgard O, Rais O, Angquist KA. Familial occurrence of abdominal aortic aneurysms. Sur¬
gery 1984; 95:650-6.
Tilson MD, Seashore MR. Human genetics of the abdominal aortic aneurysm. Surg Gynecol
Obstet 1984; 158:129-32.

55

Davies et al. - The Natural History of Thoracic Aortic Disease

102.
103.
104.
105.
106.
107.
108.
109.

110.
111.
112.

113.
114.
115.
116.

117.
118.
119.
120.
121.
122.

References

Johansen K, Koepsell T. Familial tendency for abdominal aortic aneurysms. JAMA 1986;
256:1934-6.
Powell JT, Greenhalgh RM. Multifactorial inheritance of abdominal aortic aneurysm. Eur J
Vase Surg 1987; 1:29-31.
Nicod P, Bloor C, Godfrey M, et al. Familial aortic dissecting aneurysm. J Am Coll Cardiol
1989; 13:811-9.
Hanley WB, Jones NB. Familial dissecting aortic aneurysm. A report of three cases within
two generations. Br Heart J 1967; 29:852-8.
Toyama M, Amano A, Kameda T. Familial aortic dissection: a report of rare family cluster.
Br Heart J 1989;61:204-7.
Biddinger A, Rocklin M, Coselli J, Milewicz DM. Familial thoracic aortic dilatations and dis¬
sections: a case control study. J Vase Surg 1997; 25:506-11.
Milewicz DM, Michael K, Fisher N, Coselli JS, Markello T, Biddinger A. Fibrillin-1 (FBN1)
mutations in patients with thoracic aortic aneurysms. Circulation 1996; 94:2708-2711.
Francke U, Berg MA, Tynan K, et al. A Glyl 127Ser mutation in an EGF-like domain of the
fibrillin-1 gene is a risk factor for ascending aortic aneurysm and dissection. Am J Hum Genet
1995;56:1287-96.
Murdoch JL, Walker BA, Halpem BL, Kuzma JW, McKusick VA. Life expectancy and
causes of death in the Marfan syndrome. N Engl J Med 1972; 286:804-8.
Silverman DI, Burton KJ, Gray J, et al. Life expectancy in the Marfan syndrome. Am J Car¬
diol 1995;75:157-60.
von Kodolitsch Y, Simic O, Nienaber CA. Aneurysms of the ascending aorta: diagnostic fea¬
tures and prognosis in patients with Marfan's syndrome versus hypertension. Clin Cardiol
1998;21:817-24.
Darling RCI, Brewster DC, Darling RC, et al. Are familial abdominal aortic aneurysms dif¬
ferent? J Vase Surg 1989; 10:39-43.
Webster MW, St. Jean PL, Steed DL, Ferrell RE, Majumder PP. Abdominal aortic aneurysms:
results of a family study. J Vase Surg 1991; 13:366-72.
Rutherford RB, Flanigan DP, Gupta SK, et al. Suggested standards for reports dealing with
lower extremity ischemia. J Vase Surg 1986; 4:80-94.
Dinsmore RE, Liberthson RR, Wismer GL, et al. Magnetic resonance imaging of thoracic
aortic aneurysms: comparison with other imaging methods. AJR Am J Roentgenol 1986;
146:309-14.
Goldstein LJ, Davies RR, Davila JJ, et al. Stroke in thoracic aortic surgery: incidence, im¬
pact,, etiology, and prevention. J Thorac Cardiovasc Surg 2001; [in press],
Rizzo JA, Coady MA, Elefteriades JA. Procedures for estimating growth rates in thoracic
aortic aneurysms. J Clin Epidemiol 1998; 51:747-54.
Rizzo JA, Coady MA, Elefteriades JA. Interpreting data on thoracic aortic aneurysms. Statis¬
tical issues. Cardiol Clin 1999; 17:797-805, x.
Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A laboratory manual. Vol. 2. Cold
Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press, 1989.
Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage
analysis: a unified multipoint approach. Am J Hum Genet 1996; 58:1347-63.
Milewicz DM, Chen H, Park E-S, et al. Reduced penetrance and variable expressivity of fa¬
milial thoracic aortic aneurysms/dissections. Am J Cardiol 1998; 82:474-9.

56

VALE MEDICAL LIBRARY

3 9002 011 05 9806

HARVEY CUSHING/JOHN HAY WHITNEY
MEDICAL LIBRARY
MANUSCRIPT THESES
Unpublished theses submitted for the Master’s and Doctor’s
degrees and deposited in the Medical Library are to be used only with
due regard to the rights of the authors. Bibliographical references
may be noted, but passages must not be copied without permission of
the authors, and without proper credit being given in subsequent
written or published work.
This thesis by
has been used by the following person, whose signatures attest their
acceptance of the above restrictions.

NAME AND ADDRESS

DATE

